Advanced search
Publication Cover
Journal of Microencapsulation
Micro and Nano Carriers
Volume 9, 1992 - Issue 3
Submit an article Journal homepage
5
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 393-414 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • Nanoparticles of poly-epsilon-caprolactone with digitoxin. II. Stability in biological fluids. ABERTURAS, M. R., MOLPECERES, J., GUZMAN, M., HESSI, H., PUISEUX, F., and DEVISSAGUET, J. P., An. R. Acad. Farm., 1991, 57, (1), 5–13.
  • Development and evaluation of sustained-release ibuprofen-wax microspheres. I. Effect of formulation variables on physical characteristics. ADEYEYE, C. M., and PRICE, J. C., Pharm. Res., 1991, 8, (11), 1377–1383.
  • Treatment of murine candidosis and cryptococcosis with a unilamellar liposomal am-photericin B formulation (ambisome). ADLER-MOORE, J. P., CIIIANG, S. M., SATORIUS, A., GUERRA, D., MCANDREWS, B., McMANus, E. J., and PROFFITT, R. T., J. Antimicrob. Chemother., 1991, 28, (Suppl. B), 63–72.
  • Intracavity control of laser radiation by means of a modulator based on microencapsulated liquid crystals. ADOMENAS, P., DANILOV, V. V., ZHEVLAKOV, A. P., LESHCHENKO, D. 0., SAVEL'EV, D. A., and SALUCHKO, S. F., Opt. Mekh. Prom'st, 1991, (1), 13–15.
  • Transplantation of microencapsulated bovine chromaffin cells reduces lesion-induced rotational asymmetry in rats. AEBISCHER, P., TRESCO, P. A., SAGEN, J., and WINN, S. R., Brain Res., 1991, 560, (1-2), 43–49.
  • Immunohistochemical detection of tumor specific surface protein incorporated into lipo-somes. ANN YONG Ho, and HAN GIL Soo, Korean J. Biochem., 1990, 22, (1), 65–72.
  • Evaluation of a novel non-aqueous technique for the preparation of biodegradable polymeric microspheres. AnuJA, P., TANEJA, R., and BHAGAT, H. R., Pharm. Res., 1991, 8, (10, Suppl.), S150.
  • Synthetic cationic amphiphiles for liposome. Mediated DNA transfection. AKAO, T., and OSAKI, T., Bio. Ind., 1991, 8, (4), 252–257.
  • Furosemide-loaded ethyl cellulose microspheres prepared by spherical crystallization tech-nique: morphology and release characteristics. AKBUGA, J., Int. J. Pharm., 1991, 76, (3), 193–198.
  • Effect of lipid composition of liposomes rifampicin incorporation into them. AKHREM, A. A., GUREVICH, G. L., ZHUKOVA, M. V., KISEI., M. A., KOCHNEV, V. E., SKURKO, M. E., and TSYBOVSKII, I. S., Vestsik. Akad. Nauk, BSSR., Ser. Khim. Nauk, 1991, (5), 58–61.
  • Interactions of antisense DNA oligonucleotide analogs with phospholipid membranes (lipo-somes). AKHTAR, S., BASU, S., WICKSTROM, E., and JULIANO, R. L., Nucleic Acids Res., 1991, 19, (20), 5551–5559.
  • Studies on the carboxymethyl chitosan-containing liposomes for their stability and controlled release of dapsone. ALAMEI.U, S., and RAO, K. P., J. Microencapsulation, 1991,8, (4), 505–519.
  • Specific in vivo fluorescent DNA staining using liposome-entrapped dyes. ALINO, S. F., HiI.ARIO, E., IRUARRIZAGA, A., ALFARO, J., PEREZ-YARZA, G., and UNDA, F. J., Inst. Phys. Conf. Ser., 1990, 98, (Emag-Micro 89, Vol. 2), 783–786.
  • Pharmacokinetics of stealth versus conventional liposomes: effect of dose. ALLEN, T. M., and HANSEN, C., Biochirn. Biophys. Acta, 1991, 1068, (2), 133–141.
  • Free and liposome encapsulated tobramycin as potential antivirulence agents against Pseudontonas aeruginosa. ALPAR, H. 0., ROVAMO, L., COLLIER, P. J., and BROWN, M. R. W., Thirty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, USA, 29 September-2 October 1991. Program Abstr., 1991, 31, 173.
  • Antibodies to lipids and lipid membranes: reactions with phosphatidylcholine, cholesterol, liposomes and bromelin-treated erythrocytes. AINING, C. R., Phospholipid-Binding Anti-bodies, CRC, Boca Raton, Fla, USA, 1991, pp. 73–95. Ed: Harris, E. N.
  • Antibodies to cholesterol, cholesterol conjugates, and liposomes: implications for atheroscle-rosis and autoimmunity. ALVING, C. R., and SWARTZ, G. M. JR. Crit. Rev. Immunol., 1991, 10, (5), 441–453.
  • Effect of the fungicides tributyltin acetate and tributyltin chloride on multilamellar lipo-somes: fluorescence studies. AMBROSINI, A., BERT01./, E., TANFANI, F., and ZOLESE, G., Chem. Phys. Lipids, 1991, 59, (2), 189–197.
  • Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B. ANAISSIE, E., PAETZNICK, V., PROFFITT, R., ADLER-MOORE, J., and BODEY, G. P., Eur. J. Clin. Microbial. Infect. Dis., 1991, 10, (8), 665–668.
  • A phase I study of regionally administered mitomycin microcapsules for patients with colorectal liver metastases (letter). ANDERSON, J. H., GOLDBERG, J. A., ELEY, J. G., WHATEI.EY, T. L., KERR, D. J., COOKE, T. G., and MCARDLE, C. S., Eur. J. Cancer, 1991, 27,(9), 1189–1190.
  • Microencapsulation effect on theophylline and euphylline pharmacological activities. ANDREEVA, I. N., SARAF, A. S., and MAKAROV, V. A., Farmakol Toksikol (Moscow), 1991, 54, (5), 27–29.
  • Gene transfer by liposomes. ARIGA, H., Tanpakushitsu Kakusan Koso, 1991, 36, (13), 2245-2247. Photocoloration of multilayer liposomes by a radical mechanism. ARISTARKHOV, V. M., Zh. Fiz. Khim., 1991, 65, (7), 1940–1943.
  • Model of liposome staining surface centers. ARISTARKHOV, V. M., Biofizika, 1991, 36, (3), 470–474. Immunosuppressive effect of cyclosporin A encapsulated into liposomes. ARNOUX, R., DUFOURCQ, J., SMEESTERS, C., LAI.ANNE, J., DEMINIERE, C., PENIN, E., CLERC, M., POTEAUX, L., DARTIGUES, J. F., MICHEL, A. et al., Chirurgie, 1990, 116, (8-9), 699–703.
  • Liposomes as vehicle for allergen presentation in the immunotherapy of allergic diseases. ARORA, N., and GANGAL, S. V., Allergy, 1991, 46, (5), 386–392.
  • Preparation of biodegradable microspheres and microcapsules: 2. Polylactides and related polyesters. ARSHADY, R., J. Controlled Release, 1991, 17, (1), 1–21.
  • Activity of free and liposome encapsulated streptomycin against Mycobacterium avium complex (MAC) inside peritoneal macrophages. ASHTEKAR, D., DUZGUNES, N., and GANGADHARAM, P. R. J., J. Antimicrob. Chemother., 1991, 28, (4), 615–617.
  • Liposome suppression of proliferative vitreoretinopathy. Rabbit model using antimetabolite encapsulated liposomes. Assii., K. K., ITARTZER, M., WEINRER, R. N., NEHORAYAN, M., WARD, T., and BLUMENKRANZ, M., Invest. Ophthalmol. Vis. Sci., 1991, 32, (11), 2891–2897.
  • Possibilities and problems of stabilization of liposomes by freezing and lyophilization. 2nd Comm. Influence of sucrose and sucrose palmitate stearate on the behavior of lecithin cholesterol liposomes. AUSBORN, M., and NUHN, P., PZ Wiss., 1991, 4, (1), 17–24.
  • Suppression of experimental allergic encephalomyelitis by the encephalitogenic peptide, in solution or bound to liposomes. AVRILIONIs, K., and BOGGS, J. M., J. Neuroimmunol., 1991, 35, (1-3), 201–210.
  • Influence of temperature, ionic strength, and incubation time on fluorescence spectral characteristics of hematoporphyrin in liposomes. Az' mov, B. S., SAGATOV, M. M., KATYSHEVA, K. G., CHERNYAEVA, E. B., MIRONOV, A. F., and RUMYANTSEVA, V. D., Vestn. Mosk. Univ., Ser. 3: Fiz. Astron, 1991, 32, (2), 97–99.
  • Liposome-mediated DNA uptake by sperm cells. BACHILLER, D., SCHELLANDER, K., PEI.1, J., and RUETHER, U., Mot. Reprod. Dev., 1991, 30, (3), 194–200.
  • Use of liposomes for directed drug delivery against Entamoeba histolytica. BAILEY, G. B., Report, 1990, (Order No. AD-A229 002), 20 pp.
  • Synthetic macrophages: antigen presentation by liposomes bearing class H MHC and membrane-IL 1. BAKOUCHE, 0. and LACHMAN, L. B., Top Vaccine Adjuvant Res., CRC, Boca Raton, Fla, USA, 1991, pp. 77–88. Eds: Spriggs, D. R. and KOFF, W. C.
  • Twelve-hour cardiopulmonary preservation using donor core cooling leukocyte depletion and liposomal superoxide dismutase. BANDO, K., SCHUELER, S., CAMERON, D. E., DEVALERIA, P. A., HATANAKA, M., CASALE, A. S., ZEBLEY, M. A., HuTcHiNs, G. M., REITZ, B. A., and BAUMGARTNER, W. A., J. Heart-Lung Transplant, 1991, 10, (2), 304–309.
  • Effect of colloidal carriers on the disposition and tissue uptake of doxorubicin. BAPAT, N., AL-Acm, A., and BOROUJERDI, M., Pharm. Res., 1991, 8, (10, suppl.), S257.
  • Immunohematopoietic activity of liposomal GM-CSF in normal and immunosuppressed mice. BARENHOLZ, Y., PALGI, 0., Goi.00, G., and KEDAR, E., Cytokine, 1991, 3, (5), 487. Effect of liposome encapsulated meso-2,3-dimercaptosuccinic acid (DMSA) on biochemicaland trace metal alterations in cadmium exposed rats. BEHARI, J. R., SRIVASTAVA, S., GuPTA, S., and SRIVASTAVA, R. C., Bull. Environ. Contam. Toxicol., 1991, 47, (6), 827–833.
  • Modulation of liposomal lipid peroxidation in presence of nickel by incorporation of alpha-tocopherol in the bilayer. BEHARI, J. R., GUPTA, S., SRIVAS'rAVA, S., and SRIVASTAVA, R. C., J. Microencapsulation, 1991, 8, (2), 215–220.
  • Dosage forms from polymeric prodrugs: hydrocortisone esters of hyaluronic acid. BENEDETTI, L. M., josm, H. N., GOEI, L., HUNT, J. A., CALLEGARO, L., STELI.A, V. J., and TOPP, E. M., New Polym. Mater., 1991, 3, (1), 41–48.
  • A new approach to chemoembolization for unresectable hepatocellular carcinoma using aclarubicin microspheres in combination with cisplatin suspended in iodized oil. BEPPU, T., OHARA, C., YAMAGUCHI, Y., ICHIHARA, T., YAMANAKA, T., KATAFUCHI, S., IKEI, S., MORI, K., FUKUSHIMA, S., NAKANO, M. etal., Cancer, 1991, 68, (12), 2555–2560.
  • Liposomal encapsulation and stability of dideoxyinosine triphosphate. BETAGER1, G. V., Pharm. Res., 1991, 8, (10, Suppl.), S213.
  • FC-receptor mediated delivery of antibody-liposome conjugates containing dideoxyinosine triphosphate to human monocyte-macrophages. BETAGERI, G. V., JENKINS, S. A., RAVIS, W. R., Pharm. Res., 1991, 8, (10, Suppl.), S190.
  • In vivo stability of DTPA-HSA-microspheres labeled with radiolanthanides. BEYER, G. J., BEYER, R., BERcmANN, R., KAMPF, G., NOLI., B., ROESCH, F., ScHAEFER, G., and RAVN, H. L., Zentralinst Kernforsch, Rossendorf Dresden, (Bee) ZfK, (ZfK-711,), 1990, pp. 77–80.
  • Incorporation of liposomal phytosterols into human cAls in culture: a potential in vitro model for investigating pathological effects of phytosterolemia. BHADRA, S., and SUBBIAH, M. T., Bloc/tern. Med. Metab. Biol., 1991, 46, (1), 119–124.
  • Substained release of verapamil hydrochloride from microspheres prepared with cellulose esters: biphasic drug release kinetics. BHARDWAJ, S. B., SHUKLA, A. J., BLOCK, L. H., and COLI.INS, C. C., Pharm. Res., 1991, 8, (10, Suppl.), S119.
  • Liposomes as a model for studying the effect of UV radiations on biomembranes. BRATIA, R., VISWANATHAN, P. N., and KAKKAR, P., J. Microencapsulation, 1991, 8, (3), 349–357.
  • Morphologic examination of rabbit nasal mucosa after nasal administration of degradable starch microspheres. BjoRR, E., BJURSTROM, S., and EDMAN, P., Int. J. Pharm., 1991, 75, (1), 73–80.
  • Spontaneous formation of drug-containing acrylic nanoparticles. BODMEIER, R., CHEN, H., TYLE, P., and JARosz, P., J. Microencapsulation, 1991, 8, (2), 161–170.
  • Polymer and wax microspheres prepared by emulsification techniques. BODMEIER, R., CHEN, H., and BHAGWATWAR, H., Bull. Tech. Gattefosse Rep., 1990, 83, 51–59.
  • Eudragit E microspheres containing bacampicillin: preparation by solvent removal methods. BOGATAJ, M., MRHAR, A., KRISTL, A., and KOZJEK, F., J. Microencapsulation, 1991, 8, (3), 401–406.
  • Liposomal cefoxitin improves survival in experimental fecal peritonitis. BOHNEN, J., OnuMERU, J., KRESTA, A., and SHEK, P., Thirty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, USA, September 29-October 2, 1991, Program Abstr., 1991, 31, 301.
  • A comment on the preparation of liposomes from and on the beta in equilibrium alpha acyl chain melting behaviour of rough mutant lipopolysaccharide. BRANDENBURG, K., and SEYDEL, U., Biochim. Biophys. Acta, 1991, 1069, (1), 1–4.
  • Methodology of formulation of micromatrixes for prolonged release of theophylline. BRUGUERA, J. L., LAMOISE, M., MIKI.ER, C., and TEILLAUD, E., Bull. Tech.IGattefosse Rep., 1990, 83, 33–48.
  • Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes. BULOW, R., and BOOTHROYD, J. C., J. Immunol., 1991, 147, (10), 3496–3500.
  • Complex coacervation: spontaneous microcapsule formation. BURGESS, D. J., MAREK, T. A., KWOK, K. K., and SINGFI, 0. N., Polym. Prepr. (Am. Chem. Soc. Div. Polym. Chem.), 1991,32, (1), 600–601.
  • Evaluation of liposome-encapsulated hemoglobin/LR16 formulation as a potential blood substitute. BURKE, T. G., Report, 1990, (Order No. AD-A229 090,), 9 pp.
  • Some aspects in using of liposomes for storage of neurotropic drugs. BURT, A. Yu., LENKOVSK I I, F. M., SUKHONOSHCHENKO, L. M., ABRAMOV, YU. B., and SACHKOV, V. I., Byull. Eksp. Biol. Med., 1991, 112, (11), 497–499.
  • An improved method for immunoisolation of pancreatic islet grafts within microcapsules. CALAFIORE, R., BASTA, G., FALORNI, A. JR, GAMBELUNGHE, G., and BRUNETTI, P., Diabetologia, 1991, 34, (Suppl. 2), A169.
  • Verapamil prevents the effects of daunomycin on the thermotropic phase transition of model lipid bilayers. CANAVES, J. M., FERRAGUT, J. A., and GONZALEZ-ROS, J. M., Bloc/tern. J., 1991, 279, (Pt 2), 413–418.
  • H + le - Stoichiometry of mitochondrial cytochrome complexes reconstituted in liposomes. Rate-dependent changes of the stoichiometry in the cytochrome c oxidase vesicles. CAPITANIO, N., CAPITANIO, G., DE NITTO, E., VILLANI, G., and PAPA, S., FEBS Lett., 1991, 288, (1–2), 179–182.
  • Effect of nanoparticles on transdermal drug delivery. CAPPEL, M. J., and KREnTER, J., J. Microencapsulation, 1991, 8, (3), 369–374.
  • Modulatory effect of two cardioglycosides on reconstituted sodium potassium ATPase in proteoliposomes. CAVELETTO, M., GIUNTA, C., PESSIONE, E., and PERGOLA, L., Int. J. Bloc/tern., 1991, 23, (11), 1267–1276.
  • Forced convection heat transfer in microencapsulated phase change material slurries: flow between parallel plates. CHARUNYAKORN, P., SENGUPTA, S., and ROY, S. K., HTD (Am. Soc. Mech. Eng.), 1990, 129, (Gen. Pap.: Phase Change Convect. Heat Transfer), 55–62.
  • Location and photoionization studies of a series of alkylporphyrin derivatives solubilized in dioctadecyldimethylammonium chloride and dihexadecyl phosphate vesicles. CHASTENET DE CASTAING, E., and KEVAN, L., J. Phys. Chem., 1991, 95, (24), 10178–10184.
  • In vivo protection against scorpion toxins by liposomal immunization. C1AVEZ-OLORTEGUI, C., AMARA, D. A., ROCHAT, H., Dixtz, C., and GRANIER, C., Vaccine, 1991, 9, (12), 907–910.
  • Cross-sectional structures of and drug release from polymeric microspheres prepared by solvent evaporation methods. CHEN, H., and BODMEIER, R., Pharm. Res., 1991, 8, (10, Suppl.), S148.
  • Study on targeting drug delivery system-the characteristics of methotrexate microsphere and experimental treatment of hepatic tumor in rats by arterial embolization. CHEN, Q. H., Lu, W. G., GE, Q. H., SHENG, Q., ZHANG, Y., XIE, X. H., WANG, Y., Wu, M. C., and ZHANG, X. H., Yao Hsueh Hsueh Pao, 1991, 26, (4), 293–298.
  • Study on targeting drug delivery system-the animal behavior in vivo after hepatic arterial embolization of methotrexate microsphere. CHEN, Q. H., Lu, W. G., GE, Q. H., He, W., XIE, X. H., YANG, W. Z., and LIN, G., Yao Hsueh Hsueh Pao, 1991, 26, (2), 139–143.
  • Preparation and performance of crosslinked agar encapsulated activated charcoal (CAAC-III). CHEN YUEMING, TANG XIANJUE, XU CHANGXI, and Li ZHONGMING,J.Microencapsulation, 1991,8, (3), 327–334.
  • Laser picosecond microspectrofluorometry of hematoporphyrin in cells and liposomes. CHERNYAEVA, E. B., VARDANYAN, A. G., KOROTEEV, N. I., KAMALOV, V. F., LOBANOV, 0. V., MIRONOV, A. F., and RUMYANTSEVA, V. D., J. Photochem. Photobiol. B, 1991, 10, (3), 239–248.
  • Preparation and characterization of liposomes carrying antibodies to interferon on their surface. CHERNYAVSKII, V. A., ZIBRIN, S. V., and LEBEDEV, A. D., Zh. Mikrobiol. Epidemiol. Immunobiol, 1991, (6), 65–68.
  • In vivo activation of peritoneal macrophages by the implantation of alginate-polylysine microcapsules in the BB-E rat. CHICHEPORTICHE, D., WALKER, R., and BAIRD, J. D., Diabetologia, 1991, 34, (Suppl. 2), A170.
  • Mucosal and systemic responses to an oral liposome Streptococcus mutans carbohydrate vaccine in humans. CIIILDERS, N. K., MICHALEK, S. M., PRITCHARD, D. G., and MCGHEE, J. R., Reg. Immunol., 1990-1991, 3, (6), 289–296.
  • Liposomal amphotericin B (Ambisome) in the treatment of fungal infections in neutropenic patients. CHOPRA, R., BLAIR, S., STRANG, J., CERVI, P., PATTERSON, K. G., and GOLDSTONE, A. H., J. Antimicrob. Chemother., 1991, 28, (Suppl. B), 93–104.
  • Preliminary evaluation of dika wax as a sealant in quinine hydrochloride microcapsules.
  • CHUKWU, A., AGARWAI,, S. P., and ADIKWU, M. U., STP Pharma Sci., 1991, 1, (2), 121–124. Some properties of chloroquinine phosphate and quinine hydrochloride microcapsules.
  • CHUKWU, A., AGARWAL, S. P., and ADIKWU, M. U., STP Pharma Sci., 1991, 1, (2), 117–120. On/off switching of liposome polymerization by pH adjustment. CHUNG YONG CHAN, and REGEN, S. L., Macromolecules, 1991, 24, (20), 5738–5739.
  • Obtaining liposome with different drugs and a study of their stability. CHUYESFIOV, V. I., CHERNOV, M. Yu., SHEBANOVA, S. T., HULYEVS'KYI, 0. K., KORYAZOVA, L. K., and HI.ADUKH, YE. V., Farm. Zh. (Kiev), 1991, (3), 68–71.
  • Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases. CIVALLERI, D., ESPOSITO, M., Fut.uo, R. A., VANNOZZI, M., BALLETTO, N., DECIAN, F., PERCIVALE, P. L., and MERLO, F., Cancer, 1991, 68, (5), 988–994.
  • The effect of capsule composition on the biocompatibility of alginate-poly-L-lysine capsules. CLAYTON, H. A., LONDON, N. J. M., COLLOBY, P. S., BELL, P. R. F., and JAMES, R. F. L., J. Microencapsulation, 1991, 8, (2), 221–233.
  • Efficacies of a liposomal formulation ambiosome ambi and deoxycholate suspension of amphotericin B fungizone F against murine blastomycosis. CLEMONS, K. W., and STEVENS, D. A., Thirty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, USA, 29 September-2 October 1991. Program Abstr., 1991, 31, 196.
  • The pharmacokinetics of, and humoral responses to, antigen delivered by microencapsulated liposomes. COHEN, S., BERNSTEIN, 1-I., HEWES, C., CHOW, M., and LANGER, R., PrOC. Natl. Acad. Sci. USA, 1991, 88, (23), 10440–10444.
  • Experience with liposomal amphotericin B (ambisome) in cryptococcal meningitis in AIDS. COKER, R. J., MURPHY, S. M., and HARRIS, J. R. W., J. . Antimicrob. Chemother., 1991, 28, (Suppl. B), 105–110.
  • Microencapsulated chemical sensors for shear stress determination: a method to monitor PBX extrusion processing. CONDO, A. C., KOSOWSKI, B. NI., and PLOCHOCKI, A. P., Int. Annu. Conf. ICT, 1991, 22 (Combust. React. Kinet.), 119/1–119/5.
  • Preparation and pharmacokinetic evaluation of a modified long-acting injectable noreth-isterone microsphere. CONG, H., and BECK, L. R., Adv. Contracept, 1991, 7, (2-3), 251–256.
  • Artificial carriers for radioisotopes in vivo: tumor sensitivity of MAB-labelled liposomes containing iodine-131 in colorectal cancer. Cossu, F., ROMBI, G., and MELIS, G., J. Surg. Oncol., 1991, (Suppl. 2), 180.
  • Polyalkylcyanoacrylate nanoparticles as drug carrier: present state and perspectives. COUVREUR, P., and VAUTHIER, C., J. Controlled Release, 1991, 17, (2), 187–198.
  • Liposomes and nanoparticles in the treatment of intracellular bacterial infections. COUVREUR, P., FATTAL, E., and ANDREMONT, A., Pharm. Res., 1991, 8, (9), 1079–1086.
  • Initial clinical evaluation of liposomal doxorubicin. CREAVEN, P. J., and COWENS, J. W., Cancer Invest, 1991,9, (3), 350.
  • Liposomal amphotericin B in the treatment of visceral leishmaniasis. CROFT, S. L., DAVIDSON, R. N., and THORNTON, E. A., J. Antimicrob. Chemother., 1991, 28, (Suppl. B), 111–118. Tumor targeting with particular carriers. CROMMELIN, D. J. A., Fur. J. Cancer, 1991,27, (Supp. 3), S9.
  • Opacification and border delineation improvement in patients with suboptimal endocardial border definition on routine echocardiography: results of a phase III trial of sonicated albumin microspheres. CROUSE, L. J., and KRAMER, P. H., Clin. Cardiol., 1991, 14, (11, Suppl. 5), V-19-V–22.
  • Continuous flow dissolution cells: examples of applications to microspheres at different pH values. CURTET, B., LAMOISE, M., REGINAULT, P., and TEILLAUD, E., STP Pharma, 1990,6, (9), 673–677.
  • In vivo uptake of technetium-99M labeled tyrosine-PLGA microspheres in the blood after IP administration. D'SOUZA, D. E., Pharm. Res., 1991, 8, (10, Suppl.), S262.
  • Targeting of technetium-99M radiolabeled microspheres to melanoma tumors. D'SOUZA, M. J., and ESHIMA, D., Pharm. Res., 1991, 8, (10, Suppl.), S46.
  • In vitro uptake of radiolabeled tyrosine-PLGA microspheres by the macrophages. D'SOUZA, M. J., and ESHIMA, D., Pharm. Res., 1991, 8, (10. Suppl.), S46.
  • Phospholipid studies of marine organisms 26. Interactions of some marine sterols with 1-stearoy1-2-oleoyl phosphatidylcholine (SOPC) in model membranes. DAI, M. C., CHICHE, H. B., DUZGUNES, N., AYANOGLU, E., and DJERASSI, C., Chem. Phys. Lipids, 1991, 59,(3), 245–254.
  • Polymeric microcapsules of the herbicides atrazine and metribuzin: preparation and evaluation of controlled-release properties. DAILEY, 0. D. JR, and DOWLER, C. C., Abstr. Pap. Am. Chem. Soc., 1991, 202, (1–2), AGRO 63.
  • Synergistic cytotoxic actions of cisplatin and liposomal valinomycin on human ovarian carcinoma cells. DAOUD, S. S., and FORDE, N. H., Cancer Chemother. Pharmacol., 1991, 28, (5), 370–376.
  • Effect of formulation variables on physicochemical characteristics of polyisobutylcyanoacry-late nanoparticles. DAS, S. K., TUCKER, I. G., and H11.1., D. J. T., Pharm. Res., 1991, 8, (10, Suppl.), S147.
  • Small unilamellar liposomes from mixed natural and polymeric phospholipids: stability and susceptibility to phospholipase A2. DAVIES, D. E., CRITCHLOW, M., GRAINGER, D. W., REICHERT, A., RINGSDORF, H., and LLOYD, J. B., Biochim. Biophys. Acta, 1991, 1084, (1), 29–34.
  • Using liposomes in wool chlorination: stability of chlorine liposomes and their application on wool fibers. DE LA MAZA, A., PARRA, J. L., and Bosun, P., Text. Res. J., 1991, 61, (6), 357–362.
  • Tension activity of pulmonary surfactant: adsorption of liposomes of model phospholipids. DENIZOT, B. A., FAIN, B., TCHORELOFF, P. C., BONANNO, L. M., PROUST, J. E., LINDENISAUM, A., DEHAN, M., and PUISIEUX, F., Ann. Pharm. Fr., 1991, 49, (3), 151–157.
  • Improved efficacy of cyclosporine microspheres in the treatment of polyarthritis in rats. DESouzA, P., D'SOUZA, M., and ESHIMA, D., Pharm. Res., 1991, 8, (10, Suppl.), S46.
  • Disposition of rat peritoneal macrophages after uptake of cyclosporine microspheres in vitro. DESouzA, P., ESHIMA, D., and D'SOUZA, M., Pharm. Res., 1991, 8, (10, Suppl.), S46.
  • Activation of rat complement by liposomes direct effects of cholesterol and liposome size. DEVINE, D. V., and SERRANO, K., Complement Inflammation, 1991, 8, (3-4), 140.
  • Preparation and in vitro evaluation of salbutamol sulfate microcapsules. DFIARAMADHIKARI, N. B., Josm, S. B., and MANEKAR, N. C., J. Microencapsulation, 1991, 8, (4), 479–482.
  • In vitro evaluation of albumin microspheres containing actinomycin D. DHAWAN, A., VYAS, S. P., JAIN, N. K., and VARMA, K. C., Drug Dev. Ind. Pharm., 1991, 17, (16), 2229–2237.
  • Encapsulation of ampicillin in reversed-phase evaporation liposomes: a direct evaluation by derivative spectrophotometry. DI GIULIO, A., MAURIZI, G., ODOARDI, P., SALETTI, M. A., AMICOSANTE, G., and ORATORE, A., Int. J. Pharm., 1991, 74, (2-3), 183–188.
  • Assessment of phosphatidylcholine (PC12) liposomes. DOHERTY, D. J., and HOUGHTON, J. A., Biochem. Soc. Trans., 1991, 19, (4), 434S.
  • Polymer-coated liposomes stability and release of ASA from carboxymethyl chitin-coated liposomes. DONG, C., and ROGERS, J A., J. Controlled Release, 1991, 17, (3), 217-224. Quantitative determination of carboxymethyl chitin in polymer-coated liposomes. DONG, C., and ROGERS, J. A., J. Microencapsulation, 1991, 8, (2), 153–160.
  • Behavior of radioactive albumin microspheres following their injection into the hepatic artery of animals. DROZDOVSKII, B. YA, ROZIEV, R. A., and GONCHAROVA, A. Y A, Med. Radio., 1991, 36, (7), 37–39.
  • Ibuprofen-loaded ethyl cellulose microspheres: analysis of the matrix structure by thermal analysis. DUI3ERNET, C., ROULAND, J. C., and BENOIT, J. P., J. Pharm. Sci., 1991, 80, (11), 1029–1033.
  • Microencapsulation of isolated pituitary cells by polyacrylamide microlatex coagulation on agarose beads. DUPUY, B., CADIC, C., GIN, H., BAQUEY, C., DUEY, B., and DucAssou, D., Biomaterials, 1991, 12, (5), 493–496.
  • Production of biocompatible microcapsules by seeded polymerization around agarose microspheres. DUPEY, B., CADIC, C., ROUAIS, F., BAQUEY, C., and DUCASSOU, D., Makromol. Chem., 1991, 192, (8), 1821–1827.
  • pH-sensitive liposomes: Introduction of foreign substances into cells. DuzouNEs, N., STRAUBINGER, R. M., BALDWIN, P. A., and PAPAHADJOPOULOS, D., In: N. Wilschut and D. Hoekstra (Eds), Membrane Fusion. 902 pp. Marcel Dekker, New York, N.Y., USA; 1991, pp. 713–730.
  • Topical delivery of liposomally encapsulated ingredients evaluated by in vitro diffusion studies. EGBARIA, K., and WEINER, N., Pharm. Res., 1991, 8, (10, Suppl.), S206.
  • Spectroscopic properties of the potentiometric probe merocyanine-540 in solutions and liposomes. EHRENBERG, B., and PEVZNER, E., Proc. SPIE-Int. Soc. Opt. Eng., 1991, 1432 (Biomol. Spectrosc. 2), 154–163.
  • In vitro measurement of gentamicin release from polyglycolide-co-m-lactide microspheres. EINSTEIN, A. M., BRIZZOLARA, N. S., LANZILOTTI, M. G., and GAGNON, W., Pharm. Res., 1991,8, (10, Suppl.), S8.
  • Preparation and evaluation of naproxen microcapsules. EL-HARRAS, S. A., Tous, S. S., EL-SAYED, A. M., and JUN, H. W STP Pharma Sci., 1991, 1, (4), 262–266.
  • Bioavailability studies of theophylline microcapsules. EL-SHANAWANY, S., and SAFWAT, S. M., Bull. Pharm. Sci., Assiut Univ., 1990, 13, (2), 195–203.
  • Biodegradable and biocompatible poly(m-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. ELDRIDGE, J. H., STAAS, J. K., MEULBROEK, J. A., TICE, T. R., and GILLEY, R. M., Infect. Immun., 1991, 59, (9), 2978–2986.
  • Modelling and kinetics of light induced proton pumping of bacteriorhodopsin reconstituted liposomes. EROGLU, I., ZUBAT-BAKER, M., and YUCEL, A. M., J. Membr. Sci., 1991, 61, 325–336.
  • Proton NMR studies on dipalmitoylphosphatidylcholine liposomes containing eleostearic acid. FANG YIFEI, and Li ZICHEN, Shengtuu Huaxue Yu ShenguniWuli Xuebao,1990, 22, (6), 543–549.
  • Inhibition of phosphatidylcholine liposome oxidation by porcine plasma. FARAH, H., and DECKER, E. A., J. Food Sci., 1991, 56, (4), 1038–1041.
  • Variation of the morphology of liposomes by variation of the surface ratio between inner and outer leaflet. FARGE, E., and DEVAUX, P. F. In: G. Paillotin (Ed.), American Institute of Physics Conference Proceedings, 226. The Living Cell in Four Dimensions 47th International Conference, GIF Sur Yvette, France, 1991. xiii +588 pp. American Institute of Physics: New Tork, N.Y., USA, 1991, pp. 467–475.
  • Transfer of retinol from retinol-binding protein complex to liposomes and across liposomal membranes. FEX, G., and JOHANNESSON, G., Methods Enzyrnol., 1990, 189, (Retinoids, Pt. A), 394–402.
  • Antitumor effects of alkyl phosphocholines in different murine tumor models use of liposomal preparations. FICHTNER, I., ZEISIG, R., ARNDT, D., and JUNGMANN, S., EUT J. Cancer, 1991, 27, (Suppl. 3), S52.
  • Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats. FIELDING, R. M., SMITH, P. C., WANG, L. H., PORTER, J., and Guo, L. S., Antimicrob. Agents Chemother., 1991, 35, (6), 1208–1213.
  • Topical delivery of local anesthetic agents from liposomes in vitro studies using human skin. FOLDVARI, M., and ELLIOTT, M., Pharm. Res., 1991, 8, (10, Suppl.) S208.
  • Intracellular delivery of drugs by liposomes containing Po glycoprotein from peripheral nerve myelin into human M21 melanoma cells. FOLDVARI, M., MEZEI, C., and MEZEI, M., J. Pharm. Sci., 1991, 80, (11), 1020–1028.
  • Drug release from spray-dried and spray-embedded microparticles of diltiazem hydroch-loride. FORNI, F., COPPI, G., VANDELLI, M. A., and CAMERONI, R., Chem. Pharm. Bull., 1991, 39, (8), 2091–2095.
  • Reconstitution of bacteriorhodopsin and ATP-synthase from Micrococcus luteus into lipo-somes of the main tetraether lipid from Therm oplasma acidophilum. FREISLEBEN, H. J., ZWICKER, K., BETTIN-BOGUTZKI, A., and NAWROTH, T., Biol. Chem. Hoppe Seyler, 1991, 372,(9), 655.
  • Ricin B-chain promotes the internalisation of liposomal contents into rat hepatoma cells. FRIEDE, M. H., and VON HOI.T, C., Biochim. Biophys. Acta, 1991, 1069, (2), 273–280.
  • Glucose tolerance and plasma insulin response to intravenous glucose infusion and test meal in rats with microencapsulated islet allografts. FRITSCHY, W. M., STRUBBE, J. H., WOLTERS, G. H. J., and VAN SCHILFRGAARDE, R., Diabetologia, 1991, 34, (8), 542–547.
  • Hemolytic activity of a dental adhesive monomer (4-methyacryloyloxyethoxycarbonylphtha-lie anhydride, 4-META) and its interaction with phospholipid liposomes as determined by NMR and DSC. FujisAwA, S., KADOMA, Y., and KOMODA, Y., Dent. Mater. J., 1991, 10, (1), 18–26.
  • Effect of Asp-hemolysin on liposomes and cholesterol. FUKUCHI, Y., NUMAHATA, Y., EBINA, K., and YOKOTA, K., Annu. Rep. Tohoku Coll. Pharm., 1990. 37, 129–132.
  • Microgranulation and encapsulation of pulverized pharmaceutical powders with ethyl cellulose by the Wurster process. FUKUMORI, Y., ICHIKAWA, H., YAMAOKA, Y., AKAHO, E., TAKEUCHI, Y., FUKUDA, T., KANAMORI, R., and OSAKO, Y., Chem. Pharm. Bull., 1991, 39, (7), 1806–1812.
  • Characterization of phospholipid compositions and physical properties of DMPC/bacteriorhodopsin vesicles produced by a detergent-free method. GALE, P., and WATTS, A., Biochem. Biophys. Res. Commun., 1991, 180, (2), 939–944.
  • Chemotherapeutic potential of free and liposome encapsulated streptomycin against experi-mental Mycobacterium avium complex infections in beige mice. GANGADIIARAM, P. R., ASHTEKAR, D. A., GIIORI, N., GOLDSTEIN, J. A., DEBS, R. J., and DUZGUNES, N., J. Antimicrob. Chemother., 1991, 28, (3), 425–435.
  • Poly(hydroxybutyrate-hydroxyvalerate) microspheres containing progesterone: preparation, morphology and release properties. GANGRADE, N., and PRICE, J. C., J. Microencapsulation, 1991, 8, (2), 185–202.
  • A novel cationic liposome reagent for efficient transfection of mammalian cells. GAO, X., and HUANG, L., Biochem. Biophys. Res. Commun., 1991, 179, (1), 280–285.
  • Enhancement of in vivo and in vitro T cell response against measles virus hemagglutinin after its incorporation into liposomes: effect of the phospholipid composition. GARNIER, F., FORQUET, F., BERTOLINO, P., and GERLIER, D., Vaccine, 1991, 9, (5), 340–345.
  • Fluidity of human erythrocyte ghosts. GIANNETTINI, J., CHAUVET, M., DELL-AMICO, M., CHAUTAN, M., and BOURDEAUX, M., Biochem. Int., 1991, 24, (5), 917–926.
  • Insulin-carrying microspheres, in vitro studies. GIZURARSON, S., and BECHGAARD, E., Chem. Pharm. Bull., 1991, 39, (7), 1892–1893.
  • Effect of herbicides on phase transitions of dipalmitoyl phosphatidylcholine vesicles. GLASS, R.
  • L., Chem. Phys. Lipids, 1991, 59, (1), 91–95.
  • In vivo oximetry using a nitroxide-liposome system. GLOCKNER, J. F., CHAN, H. C., and SWARTZ, H. M., Magn. Reson. Med., 1991, 20, (1), 123–133.
  • Development of injectable antitumor microspheres based on polyphosphazene. GOEDEMOED, J. H., MENSE, E. H. G., DE GROOT, K., CLAESSEN, A. M. E., and SCHEPER, R. J., J. Controlled Release, 1991, 17, (3), 245–258.
  • Liposomes and pulmonary alveolar macrophages: functional and morphologic interactions. GONZALEZ ROTHI, R. J., STRAUB, L., CACACE, J. L., and SCHREIER, H., Exp. Lung Res., 1991, 17, (4), 687–705.
  • Evidence that liposome incorporation of cyclosporine reduces its toxicity and potentiates its ability to prolong survival of cardiac allografts in mice. GORECKI, D. C., JAKOBISIAK, M., KRUSZEWSKI, A., and LASEK, W., Transplantation, 1991, 52, (5), 766–769.
  • Liposomes in haematology. GRAY, A., and MORGAN, J., Blood Rev., 1991, 5, (4), 258–271.
  • Overview of liposomes. GREGORIADIS, G., J. Antimicrob. Chemother., 1991, 28, (Suppl. B), 39–48. The use of macromolecular protease inhibitors to study liposome-cell interactions. GREIDZIAK, M., and LASCH, J., Biomed. Biochim. Acta, 1991, 50, (8), 975–980.
  • Characterization and chemical stability of vitamin K3 (menadione sodium bisulfite) microen-capsulated with a poly(dimethylsiloxane) (PDMS) polymer membrane by spray drying. GRONCHI, P., DEL Rosso, R., CENTOLA, P., and COSENTINO, R. F., Chim. Ind. (Milan), 1991, 73, (4), 257–261.
  • Fluorocarbons encapsulated in phospholipid vesicles. GROSS, U., KOLDITZ, L., PAPKE, G., and RUEDIGER, S., J. Fluorine Chem., 1991, 53, (2), 163–170.
  • Interaction of liposomal gentamicin with human peripheral luekocytes. GUBENKO, L. V., GULYAEV, A. YE, KIVMAN, G. VA, NISNEVICH, M. M., and TROFIMOV, V. I., Khim. Farm. Zh., 1991, 25, (10), 25–27.
  • The toxicity antitumor effects and distribution of doxorubicin liposomes in mice. Guo, X., and XIE, X., Pharm. Res., 1991, 8, (10, Suppl.), S214.
  • The formulation and stability of liposome-encapsulated doxurubicin. Guo, X., and XIE, X., Pharm. Res., 1991, 8, (10, Suppl.), S213.
  • Solubilization of liposomes by metropolol. HABIB, M. J., AKOGYERAM, C. 0., NGOFA, E. N., BISWAS, M., and BETAGERI, G. V., Pharm. Res., 1991, 8, (10, Suppl.), S213.
  • A lipophilic complex with rhenium-186/rhenium-188 incorporated in liposomes suitable for radiotherapy. HAEFELI, U., TIEFENAUER, L. X., SCHUBIGER, P. A., and WEDER, H. G., Nucl. Med. Biol., 1991, 18, (5), 449–454.
  • An improved method for entrapment of plasmids in liposomes. HAGA, N., and YAGI, K., J. Clin. Biochem. Nutr., 1989, 7, (3), 175–183.
  • Polysuccinyl-co-tetraiodophenolphthalein nanoparticles for contrast enhancement of liver ct characterization and efficacy. HANNIBAL, D., and JAY, M., Pharm. Res., 1991,8, (10, Suppl.), S185.
  • Liposome-encapsulated antigens engender lysosomal processing for class II MHC present-ation and cytosolic processing for class I presentation. HARDING, C. V., COLLINS, D. S., KANAGAWA, 0., and UNANUE, E. R., J. Immunol., 1991, 147, (9), 2860–2863.
  • Steric stabilization of microspheres with grafted polyethylene oxide reduces phagocytosis by rat Kupffer cells in vitro. HARPER, G. R., DAVIES, M. C., DAVIS, S. S., TADROS, T. F., TAYLOR, D. C., IRVING, M. P., and WATERS, J. A., Biomaterials, 1991, 12, (7), 695–700.
  • Generation of recombinant baculovirus via liposome-mediated transfection. HARTIG, P. C., CARDON, M. C., and KAWANISHI, C. Y., Biotechniques, 1991, 11, (3), 310, 312–313.
  • Relation between order-disorder transition of multilayer liposome adsorbing biomaterials and bound water. HASHIMOTO, M., AKABANE, Y., and MISHIMA, K., Jpn. J. Physiol., 1991, 41, (Suppl.), S49.
  • Use of amino resin microcapsule dispersions in cosmetics. HERMA, H., BONATZ, E., and Goi.z, K., Parfuem Kosmet., 1991, 72, (7), 434–436.
  • Calcium phosphate-induced fusion of human erythrocyte ghosts monitored by dilution of a membrane bound fluorescence probe. HERRMANN, A., and HILLEBRECHT, B., Biomed. Biochim. Acta, 1991, 50, (3), 251–256.
  • Distribution of liposome-incorporated carboxyfluorescein in rabbit eyes. HIRNI.E, E., HIRNI.E, P., and WRIGHT, J. K., J Microencapsulation, 1991, 8, (3), 391–399.
  • Delivery of antigen presenting liposomes in vivo: effect on recurrent genital HSV-2 infection in guinea-pigs. Ho, R. J. Y., Pharm. Res., 1991, 8, (10, Suppl), S214.
  • Immunotherapy of murine visceral leishmaniasis with murine recombinant interferon-gamma and MTP-PE encapsulated in liposornes. HOCKERTZ, S., FRANKE, G., PAULIN', I ., and LOHMANN-MATTHES, M. L., J. Interferon Res., 1991, 11, (3), 177–185.
  • Photosensitized production of singlet oxygen by merocyanine 540 bound to liposomes. HOEBEKE, M., PIETTE, J., and VAN DE VORST, A., J. Photochem. Photobiol. B, 1991,9, (3-4), 281–294.
  • Mannitol and ergosterol as markers of invasive pulmonary aspergillosis and of response to liposomal amphotericin B. HOFFMAN, A., LEE, J., PETER, J., SHELHAMER, J., PIZZO, P., and WALSH, T., Thirty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, USA, 29 September-2 October 1991. Program Abstr., 1991, 31, 300.
  • Inhibition of copper-associated erythrocyte ghost membrane lipid peroxidation by hepatic cytosolic low molecular weight proteins. HOMER, B. L., PIERCE, K. R., BRIDGES, C. H., WO/VIACK, J. E., SOWA, B. A., and LITTELL, R. C., Toxicol. Pathol., 1991, 19, (3), 206–213.
  • Fusion of liposomes induced and modulated by proteins and polypeptides. HONG, K., MEERS, P. R., DUZGUNES, N., and PAPAHADJOPOULOS, D. In: J. Wilschut and D. Hoekstra (Eds), Membrane Fusion. 902 pp. Marcel Dekker: New York, N.Y. USA, 1991, pp. 195–208.
  • Dynamic features of a biconcave-shape liposome. HOTANI, H., SEKIMURA, T., and MIYATA, H., Biorheology, 1991, 28, (5), 436.
  • The cytotoxicity of mitomycin C-containing targeted immunoliposomes on gastric carcinoma M85 cells in vitro. Hu LANRONG, QI XIAOFENG, ZHENG GHANGXUE, Wu JIAN and DONG ZHIWEI, Shengwu Huaxue Zazhi, 1991, 7, (3), 381–383.
  • Preparation, identification and functional studies on liposome (ApoA-I : PC). Hu YONGMEI, WU
  • GANG, XUE HONG and WANG KEQIN. Zhongguo Yixue Kexueyuan Xuebao, 1990, 12, (6), 396-400. Interactions of liposomes with cells. HUANG, L., and PARK, Y. S., Ann. 'Warned. Eng., 1991, 19, (5), 593-598.
  • Light microscopic localization of silver-enhanced liposome-entrapped colloidal gold in mouse tissues. HUANG, S. K., HONG, K., LEE, K. D., PAPAHADJOPOULOS, D., and FRIEND, D. S., BMchim. Biophys. Acta, 1991, 1069, (1), 117–121.
  • The preparation and characteristics of immunoliposomes for targeting to tumor cells (A 431). HUDSON, M. J., and JONES, M. N., Biochem. Soc. Trans., 1991, 19, (4), 4155.
  • The effect of the uptake of particles on the chemotaxis of polymorphonuclear leukocytes in vitro. HYDE, R., LEWIS, D. A., and TAYLOR, P. W., J. Pharm. Pharmacol., 1991,43, (10), 728–730.
  • Preparation and evaluation of sustained release ethyl cellulose encapsulated aspirin. IBRAHIM, S. A., SAYED, H. A., HAFEZ, E., EL-SAYED, A. M., and AL, S. S., Bull. Pharm. Sci. Assiut Univ., 1990, 13, (2), 235–246.
  • Increased tumor cisplatin levels in heated tumors in mice after administration of thermosen-sitive, large unilamellar vesicles encapsulating cisplatin. IGA, K., HAMAGLICHI, N., IGARI, Y., OGAWA, Y., TOGUCHT, H., and SHIMAMOTO, T., J. Pharm. Sci., 1991, 80, (6), 522–525.
  • Biodegradation and antitumour effect of adriamycin-containing poly-L-lactic acid micro-spheres. IKE, 0., SHIMIZU, Y IKADA, Y., WATANABE, S., NATSUME, T., WADA, R., HYON, S. H., and HITOMI, S., Biomaterials, 1991, 12, (8), 757–762.
  • The in vivo distribution of the technetium-99m labeled albumin and gelatin microspheres of a tuberculostatic agent, rifampicin. Ism, E., ERCAN, M. T. KAS, H. S., and HINCAL, A. A., Boll. Chim. Farm., 1991, 130, (2), 66–70.
  • Interaction of recombinant human interferon-gamma with liposomes. ISHIHARA, H., HARA, T., ARAMAKI, Y., TsucillYA, S., and Hosoi, K., Chem. Pharm. Bull., 1991, 39, (6), 1536–1539.
  • Safety and efficacy of sonicated albumin microspheres in perfusion and vein graft patency assessments. IsmAIL, S., JOHNSON, S. H., UTSUNOMIYA, H., CRAIG, D., KISSLO, J. A., and SMITH, P. K., Clin. Cardiol., 1991, 14, (11, Suppl. 5), V-29-V–32.
  • Survival of larval giant tiger prawns (Penaeus monodon) after addition of killed vibrio cells to a microencapsulated diet. ITAmi, T., TAKAHASHI, Y., YONEOKA, K., and YAN, Y., J. Aquat. Anim. Health, 1991, 3, (2), 151–152.
  • Coacervates of gelatin. IZMAILOVA, V. N., YAMPOL'SKAYA, G. P., LEVACHEV, S. M., TULOVSKAYA, Z. D., and BERDNIKOV, V. R., Probl. Tsvetofot. Protsessov, M.P., 1990, 057–168.
  • Microencapsulation and the food industry. JACKSON, L. S., and LEE, K., Lebensm. Wiss. Technol., 1991, 24, (4), 289–297.
  • Microencapsulated iron for food fortification. JACKSON, L. S., and LEE, K., J. Food Sci., 1991, 56, (4), 1047-1050.
  • Microencapsulated iron and calcium for fortification of cheese. JACKSON, L. S., University of Wisconsin, Madison, WI, USA, Dissertation, 1990, 244 pp.
  • Chromatographic fractionation of nucleic acids using microcapsules made from plant cells. JAESCHKE, A., CECH, D., and EHWALD, R., J. Chromatogr., 1991, 585, (1), 57–66.
  • Development of a biodegradable microsphere formulation for the sustained release of a bioactive peptide. JEYANTHI, R., TSAI, T., MEHTA, R. C., and DEI.UCA, P. P., Pharm. Res., 1991, 8, (10, Suppl.), S151.
  • Studies of sea buckthorn seed oil and sea buckthorn seed oil fortified with sodium selenite in vivo on sodium, potassium-ATPase activity in erythrocyte ghosts in rats. JI YIANBIN, and GAO Y1NG. Yingyang Xuebao, 1991, 13, (1), 20–24.
  • Effect of feeding of sea buckthorn seed oil and sea buckthorn seed oil supplemented with sodium selenite in vivo on structural stability of erythrocyte ghosts in rats. JI YIANBIN and GAO YING. Shengum Huaxue Zazhi, 1991, 7, (4), 441–446.
  • Stability of atriopeptin III in poly(m-lactide-co-glycolide) microspheres. JOHNSON, R. E., LANASKI, L. A., GUPTA, V., GRIFFIN, M. J., GAUD, H. T., NEEDHAM, T. E., and ZIA H., J. Controlled Release, 1991, 17, (1), 61–67.
  • Mechanisms of effect of liposomes and niosomes with cell membranes. JUNGINGER, H. E., HOFI.AND, H. E. J., and BOOWSTRA, J. A., Pharm. Ztg., 1991, 136, (26), 9–12. 14–15. 18, 23–24. Liposomes and niosomes. Part 1. Preparation and testing. JUNGINGER, H. E., HOFI.AND, H. E. J., and BoLJWSTRA, J. A., Pharm. Zig., 1991, 136, (25), 9–14. 18, 21.
  • Liposomes and niosomes: interactions with human skin. JUNGINGER, H. E., HOFI.AND, H. E. J., and BOUWSTRA, J. A., Cosmet Toiletries, 1991, 106, (8), 45–50.
  • Influence of injection volume on the release kinetics of liposomal chloroquine administered subcutaneously or intramuscularly to mice. KADIR, F., ELINO, W. M. C., CROMMELIN, D. J. A., and ZUIDEMA, J., J. Controlled Release, 1991, 17, (3), 277–284.
  • Shape transitions and shape stability of giant phospholipid vesicles in pure water induced by area-to-volume changes. KAES, J., and SACKMANN, E., Biophys. J., 1991, 60, (4), 825–844. Antitumor activity of liposome-encapsulated cortifen administered into mice with solid tumors. KALEDIN, V. I., and KURUNOV, Yu. N., Eksp Onkol., 1991, 13, (2), 65–67.
  • Alterations of biophysical properties of liposomes predict aminoglycoside toxicity: inhibitory effect of polyaspartic acid. KALOYANIDES, G. J., and RAMSAMMY, L., Nephrotoxicity. Dekker, New York, NY, USA, 1991, pp. 117–125. Ed: P. H. Bach.
  • Preparation and characterization of immunoliposomes for targeting of antiviral agents. KALVAKOLANU, D. V., and ABRAHAM, A., Biotechniques, 1991, 11, (2), 218–222. 224–225.
  • Effects of hepatic stimulatory factor released from free or microencapsulated hepatocytes on galactosamine induced fulminant hepatic failure animal model. KASHANI, S. A., and CHANG, T. M. S., Biomater. Artif. Cells Immobilization Biotechnol., 1991, 19, (3), 565–578.
  • The preparation and characterization of proteoliposomes for targeting to oral bacteria. KASZUBA, M., FRANKLIN, M., HILL, K. J., and JONES, M. N., Biochem. Soc. Trans., 1991, 19, (4), 416S.
  • Ethyl cellulose microspheres effect of polymer viscosity on morphology and release charac-teristics. KATIKANENI, P. R., UPADRASHTA, S. M., HILEMAN, G. A., and CUTRERA, M. A., Pharm. Res., 1991, 8, (10, Suppl.), S149.
  • Measurement of the complement activities by liposomes. KATO, S., SADA, E, KisnIMURA, M., and FUKUDA, H., Bio. Ind., 1991, 8, (6), 406–411.
  • Immunomodulatory activity of liposomal IL-2 (LIP-IL-2) and pegilated IL-2 (PEG-IL-2) in mice. KEDAR, E., RUTKOWSKI, Y., BRAUN, E., EMANUEI., N., and BAREHOLZ, Y., Cytokine, 1991,3, (5), 490.
  • Incorporation and activation of a membrane-bound enzyme in bilayers of liposomes.
  • KFIEIROLOMOOM, A., MIYAZATO, K., KATOH, S., and SADA, E., Appl. Microbiol. Biotechnol., 1991, 35, (4), 521–524.
  • Synthesis characterization and biological studies of lipophilic cisplatin analogs entrapped in liposomes. KHOKHAR, A. R., AL-BAKER, S., KRAKOFF, I. H., and PEREZ-SOLER, R., Cancer Drugs Des., 1991, 6, (4), 230.
  • Effects of cholesterol- or 7-ketocholesterol-containing liposomes on colony-forming ability of cultured cells. KHOKHLOV, A. N., PROKHOROV, L. Yu, IvANov, A. S., and ARCHAKOV, A. I., FEBS Lett., 1991, 290, (1-2), 171–172.
  • Enhancement of ultraviolet-DNA repair in denV gene transfectants and T4 endonuclease V-liposome recipients. KIBITEL, J. T., YEE, V., and YAROSH, D. B., Photochem. Photobiol., 1991, 54, (5), 753–760.
  • Augmentation of macromolecular mass transport in sheared suspensions: the effective diffusivity of gamma globulin in red blood cell ghosts suspensions. KIM, D., Illinois Institute of Technology, Chicago, IL, USA, Dissertation, 1990, 135 pp.
  • Slow release of microencapsulated model compounds of insect pheromone using low molecular weight polyethylene and urea-formaldehyde resin. Kim JUNG HAN, Ott WON TEAK, and Kim YONG J IN, Han'guk Nonghwa Hakhoeche, 1991, 34, (2), 110–116.
  • Quasielastic light-scattering studies on the interactions of short chain n-alkanols with stratum corneurn lipid liposomes (SCLL). KIM, Y. H., Liu, C. L., HiGunnt, W. I., HERRON, J. N., and ABRAHAM, W., Pharm. Res., 1991, 8, (10, Suppl.), S144.
  • Stabilization of ascorbic acid by microencapsulation in liposomes. KIRBY, C. J., WHITTLE, C. J., RIGBY, N., COXON, D. T., and LAW, B. A., Int. J. Food. Sci. Technol., 1991, 26, (5), 437–450.
  • A measurement of complement activity using immunoliposome. KISH IMURA, M., YAmAji, H., FUKUDA, H., TERASHIMA, M., KATOH, S., SADA, E., and TANIGUCHI, H., Ann. NY Acad. Sci., 1990, 613 (Enzyme Eng. 10), 405–409.
  • Mutual recognition between polymerized liposomes III. Association processes between avidin and biotin on polymerized liposome surfaces. KITANO, H., KATO, N., and IsE, N., Biotechnol. Appl. Biochem, 1991, 14, (2), 192–201.
  • Targeting of macromolecular carriers and liposomes by antibodies to myosin heavy chain.
  • KLIBANOV, A. L., KHAW, B. A., NOSSIFF, N., O'DONNELL, S. M., HUANG, L., SLINKIN, M. A., and TORCHILIN, V. P., Am. J. Physiol., 1991, 261, (4, Suppl.), 60–65.
  • Treatment of experimental genital herpes with liposomal interferon. KOBRINSKII, G. D., MELNIKOV, V. R., KULAKOV, V. N., L'vov, N. D., BOLOTIN, I. M., and BARINSKII, I. F., Biomed. Sci., 1991, 2, (1), 29–32.
  • Cellular immune response found following in vitro immunization with microencapsulated AF-R1 pilus protein. KODAK, J. A., REID, R. H., JARBOE, D. L., DAVIS, D., BOEDEKER, E. C., NELLORE, R., and BHAGAT, H. R., Pharm. Res., 1991, 8, (10, Suppl.) S165.
  • The effect of supplying rats with vitamin K and administration of pelentane on Na, K- and spectrin-dependent ATPase in erythrocyte ghosts. KODENTSOVA, V. M., Soxot.'Nixov, A. A., VRZHESINSKAIA, 0. A., and SPIRICHEM, V. B., Biokhimiia, 19991, 56, (4), 727–732.
  • Anthrax toxin protective antigen: low-pH-induced hydrophobicity and channel formation in liposomes. KOEHLER, T. M., and COLLIER, R. J., Mol. Microbiol., 1991, 5, (6), 1501–1506. Proteinoid microspheres and the process of prebiological photophosphorylation. KOLESNIKOV, M. P., Origins Life Evol. Biosphere., 1991, 21, (1), 31–37.
  • Inhibition of growth of rat hepatoma by local injection of liposomes containing recombinant interleukin-2. Antitumor effect of IL-2 liposome. KONNO, H., YAMASHITA, A., TADAKUMA, T., and SAKAGUCHI, S., Biotherapy, 1991, 3, (3), 211–218.
  • Enhancement of human immunodeficiency virus type 1 infection by cationic liposomes: the role of CD4, serum and liposome-cell interactions. KONOPKA, K., STAmATATos, L., LARSEN, C. E., DAVIS, B. R., and DUZGUNECS, N., J. Gen. Viral., 1991, 72, (Pt 11), 2685–2696.
  • Topical liposome drugs to come: what the patent literature tells us. A review. KORTING, H. C., BLECHER, P., SCHAEFER- KORTING, M., and WENDEL, A., J. Am. Acad. Dermatol., 1991,25, (6, Part 1), 1068–1071.
  • An experimental study of tumor-tropic properties of radionuclide-labeled liposomes.
  • KOSTENIKOV, N. A., FADEEV, N. P., SERZHANINA, V. A., KORSAKOVA, L. N., and ROZENBERG, 0. A., Med. Radio. (Mosk.), 1991, 36, (9), 39–41.
  • Whole-body autoradiographic studies of the distribution of astatine-211-HSA-microspheres in mice with Ehrlich ascites tumor. KRETZSCHMAR, M., BEYER, R., REDOW, J., WUNDERLICH, G., and REIMANN, T., Zentralinst. Kernforsch., Rossendorf Dresden, (Bee.) ZfK, (ZfK-711,), 1990, 76–77.
  • Peroral administration of nanoparticles. KnEuTER, J., Adv. Drug Delivery Rev., 1991, 7, (1), 71–86. In vivo tissue distribution studies of poly-m-lactide microcapsules loaded with ethyl iopanoate. KUANG, L. R., YANG, D., SAKAGUCHI, H., MOULT, R., Li, C., and WALLACE, S., Pharm. Res., 1991, 8, (10, Suppl.), S150.
  • The size of enteric coated microspheres influences the intraduodenal lipolytic activity. KUEHNEL, T. P., MUNDLOS, S., and ADLER, G., Z. Gastroenterol., 1991, 29, (9), 417–421.
  • Application of microencapsulation technology to improve the stability of citral in rodent diets. KUHN, G. 0., MCCAMPBELL, P., SINGMASTER, G., ARNESON, D. W., and JAMESON, C. W., Fundam. Appl. Toxicol., 1991, 17, (3), 635–640.
  • Changes in cell ultrastructure of the Walker carcinosarcoma induced by free and microsphere-based doxorubicin in Wistar rats. KULABUKHOVA, T. K., YAGUBOV, A. S., SINITSKAYA, S. A., RUSAKOV, I. G., and SHCHITKOV, K. G., Eskp. Onkol., 1991, 13, (5), 64–67.
  • Diffusional release from salt-walled microcapsules. KULKARNI, A. V., and SPEAKER, T. J., Pharm. Res., 1991, 8, (10, Suppl.) S163.
  • Characterization of aerosol formulations of biodegradable microspheres. KULKARNI, M., PHILIP, V., DOLL, W., MEHTA, R., and DELUCA, P., Pharm. Res., 1991, 8, (10, Suppl.), S86.
  • Selective killing of HIV-infected cells by liposomes composed of dimyrist-oylphosphatidylcholineiphosphatidylserineicholesterol. KUMAGAI, K., NABESHIMA, S., KATO, S., WATANABE, M., and IKUTA, K., Antiviral Chem., 1991, 2, (3), 143–148.
  • Quantitative analysis of the stability of liposomes in blood in vivo. KUME, Y., YAMANE, C., HARASHIMA, H., and KIWADA, H., Yakubutsu Dotai, 1991, 6, (2), 201–208.
  • Anionic reversed vesicles. KUNIEDA, H., MAKINO, S., and USHIO, N., J. Colloid Interface Sci., 1991, 147, (1), 286–288.
  • Interactions between local anesthetics and erythrocyte ghost and sonicated egg phosphatidyl-choline membranes as studied by noesy and roesy methods in proton NMR spec-troscopy. KURODA, Y., WAKITA, M., FUJIWARA, Y., and NAKAGAWA, T. In: R. E. Hester and R. B. Girling (Eds), Spectroscopy of Biological Molecules: Fourth European Conference on the Spectroscopy of Biological Molecules, York, England. UK, 1–6 September 1991. 464 pp. Royal Society of Chemistry: Cambridge, England, UK. 1991, pp. 171–172.
  • Ultrastructural study of DNA liposome magnesium complexes. KUVICHKIN, V. V., Biophysics (Engl. Transl. Biofizika), 1990 (1991), 35, (2), 253–260.
  • Release of human lysozyme via ion exchange from albumin-heparin microspheres. KWON, G. S., BAE, Y. H., CREMERS, H., FEIJEN, J., and Kim, S. W., Pharm. Res., 1991, 8,(10, Suppl.), S164.
  • Biodegradable nanospheres containing phthalocyanines and naphthalocyanines for targeted photodynamic tumor therapy. LABIB, A., LENAERTS, V., CHOUINARD, F., LEROUX, J. C., GUELLET, R., and VAN LIER, J. E., Pharm. Res., 1991, 8, (8), 1027–1031.
  • Prolonged bronchodilator effects of isoproterenol microspheres. LAI, Y. L., THACKER, A. A., MEHTA, R. C., and DELUCA, P. P., Pharm. Res., 1991, 8, (10, Suppl.) S149.
  • Inhibition of autoxidation of egg yolk lecithin in solvent solution and liposomes by oxidized and reduced coenzyme Q. LANDI, L., FIORENTINI, D., STEFANELLI, C., SECHI, A. M., PASQUALI, P., and PEDULLI, G. F., Biomed. Clin. Aspects Coenzyme Q, 1991, 6 (Biomed. Clin. Aspects Coenzyme Q), 81–88.
  • Penetration enhancement of steroid hormones in human skin by intact? liposomes. LASCH, J WOHLROB, W., and LAUB, R., Biol. Chem. Hoppe Seyler, 1991, 372, (9), 703.
  • Stealth liposomes. LASIC, D. D., MARTIN, F. J., and MAYHEW, E., Ann. Biomed. Eng., 1991, 19, (5), 594. Alteration in KI 67-positive growth fraction of cultured human keratinocytes by exposure with liposomes. LAUB, R., BONNEKOH, B., and MAHRLE, G., Dermatol. Monatsschr., 1991, 177, (6), 343-347–
  • Effect of stabilization temperature on the degradation of adriamycin in albumin micro-spheres. LAW, S. L., CHIANG, C. H., LIN, F. M., and TEH, G. W., Biomater. Artif. Cells Immobilization Biotechnol., 1991, 19, (3), 613–630.
  • In vivo arterial gene transfer in the normal rabbit characterization of long-term expression following liposome-mediated transfection. LECLERC, G., GAL, D., NixoL, S., KEARNEY, M., DONOVAN, C., HOGAN, J., WEIR, L., and ISNER, J. M., Circulation, 1991, 84, (4, Suppl. 2), 11295.
  • In vivo assessment of salmon calcitonin sustained release from biodegradable microspheres. LEE, K. C., SOI.TIS, E. E., NEWMAN, P. S., BURTON, K. W., MEHTA, R. C., and DELUCA, P. P., J. Controlled Release, 1991, 17, (2), 199–205.
  • Swelling-induced zero-order drug release from polydimethylsiloxane microspheres. LEE, P. I., and Kum, S. K., Pharm. Res., 1991, 8, (10, Suppl.), S163.
  • Expression of recombinant luciferase in mammalian cells after plasmid delivery via pH-sensitive liposomes or lipofectin. LEGENDRE, J. Y., GREEN, G. A., and SZOKA, F. C., Pharm. Res., 1991, 8, (10, Suppl.), S53.
  • Liposomes and cell targeting of nucleic acids. LESERMAN, L. In: 0. Cohen-Haguenauer and M. Boiron (Eds), (INSERM (National Institute of Health and Medical Research) Colloquium), Vol. 219. Human Gene Transfer); International Workshop, Gouvieux-Chantilly, France, 11–13 April 1991. 364 pp. John Libbey Eurotext: London, England, UK. 1991, pp. 75–82.
  • Mixed-walled microcapsules made of cross-linked proteins and polysaccharides: preparation and properties. LEVY, M. C., and ANDRY, M. C., J. Microencapsulation, 1991, 8, (3), 335–347.
  • Fourier transform infrared spectroscopic studies of human serum albumin microscapsules prepared by interfacial cross-linking with terephthaloylchloride: influence of poly-condensation pH spectral and relation with microcapsule morphology and size. LEVY, M. C., LEFEBVRE, S., RAHMOUNI, M., ANDRY, M. C., and MANFAIT, M., J. Pharm. Sci., 1991, 80, (6), 578–585.
  • Autoantibodies to GM1 ganglioside: different reactivity to GM1-liposomes in amyotrophic lateral sclerosis and lower motor neuron disorders. Li, F., and PESTRONK, A., J. Neurol. Sci., 1991, 104, (2), 209–214.
  • Encapsulation of drugs into large unilamellar liposomes prepared by an extemporaneous method. LIAUTARD, J., PHILIPPOT, J. R., and LIAUTARD, J. P., J. Microencapsulation, 1991,8, (3), 381–389.
  • Pilosebaceous unit delivery of carboxyfluorescein (CF) from MLV liposomes using male Syrian hamster ear model and two new fluorescent techniques. LIEB, L. M., RAMACHANDRAN, C., and WEINER, N., Pharm. Res., 1991, 8, (10, Suppl.), S200.
  • Liposomes for drug targeting in cancer chemotherapy. LILIEMARK, J., Eur. J. Surg. Suppl., 1991, (561), 49–52.
  • Tablet formulation study of spray-dried sodium diclofenac enteric-coated microcapsules. LIN, S., and KAO, Y. H., Pharm. Res., 1991, 8, (7), 919–924.
  • Preparation of enteric-coated microspheres of Mycoplasma hyopneumoniae vaccine with cellulose acetate phthalate: I. Formation condition and micromeritic properties. LIN, S. Y., TZAN, Y. L., LEE, C. J., and WENG, C. N., J. Microencapsulation, 1991, 8, (3), 317–325.
  • Preparation of enteric-coated microspheres of Mycoplasma hyopneumoniae vaccine with cellulose acetate phthalate: (II). Effect of temperature and pH on the stability and release behavior of microspheres. LIN, S. Y., TZAN, Y. L., WENG, C. N., and LEE, C. J., J.
  • . Microencapsulation, 1991, 8, (4), 537–545.
  • Mechanism of lung absorption and metabolism of free and liposomal insulin. Liu, F. Y., KILDSIG, D. 0., and MITRA, A. K., Pharm. Res., 1991, 8, (10, Suppl.), S166.
  • Limited protection by small unilamellar liposomes against the renal tubular toxicity induced by repeated amphotericin B infusions in rats. LONGIJET, P., JoLY, V., AMIRAULT, P., SETA, N., CARBON, C., and YEN, P., Antimicrob. Agents Chemother., 1991, 35, (7), 1303–1308.
  • Improvement of ocular penetration of amikacin sulphate by association to poly(butylcyanoacrylate) nanoparticles. LosA, C., CALVO, P., CASTRO, E., VILA-JATO, J. L., and At,oxso, M. J., J. Pharm. Pharmacol., 1991, 43, (8), 548–552.
  • Macrophage depletion using clodronate encapsulated within small unilamellar liposomes. LOVE, W. G., CAMILLERI, J. P., DOUGLAS-JONES, A. G., and WILLIAMS, B. D., Arthritis Rheum., 1991, 34, (9, Suppl.), S166.
  • The role of envelope glycoproteins in the fusion of sendai virus with liposomes. LOYTER, A., and CITOVSKY, V. In: J Wilschut and D. FIoekstra (Eds), Membrane Fusion. 902 pp. Marcel Dekker, New York, NY, USA; 1991, pp. 375–394.
  • Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets. Lum, Z. P., TAI, 1. T., KRESTOW, M., NORTON, J., VACEK, I., and SUN, A. M., Diabetes, 1991, 40, (11), 1511–1516.
  • Preliminary study on the transformation of liposome-mediated chromosome DNA in Streptomyces fradiae. LIJO ZONGSHU and Li HUANLOU. Zhongguo Kangshengsu Zazhi, 1989, 14, (6), 411–414.
  • Partitioning of a homologous series of alkyl-p-aminobenzoates in dipalmitoylphosphatidyl-choline liposomes: effect of liposome type. MA, L., RAMACHANDRAN, C., and WEINER, N. D., Int. J. Pharm., 1991, 77, (2-3), 127–140.
  • Restricted diffusion and stability of carbachol-fluorescent nanospheres in vivo. MACKLIS, J. D., and QUATTROCH I, J. J Neuroreport, 1991, 2, (5), 247–250.
  • Nanoparticle characterization: a comprehensive physicochemical approach. MAGENHEIM, B., and BENITA, S., STP Pharma Sci., 1991, 1, (4), 221–241.
  • Stability of anthralin in liposomal phospholipids. MAIIRLE, G., BONNEKOH, B., GHCZY, M., and WIEGREBE, W., Arch. Dermatol. Res., 1991, 283, (7), 483–484.
  • Rheological behavior of polymerized vesicle suspensions. MAKINO, C., KIMURA, N., HASEGAWA, E., and TSUCHIDA, E., Nippon Kagaku Kaishi, 1991, (8), 1102–1107.
  • Self-regulated delivery of insulin from microcapsules. MAKINO, K., MACK, E. J., OKANO, T., and Kiss, S. W., Biometer. Arti f. Cells, Immobilization Biotechnol, 1991, 19, (1), 219–228.
  • Therapy of human ovarian cancer xenografts with intraperitoneal liposome encapsulated muramyl-tripeptide phosphatidylethanolamine (MTP-PE) and recombinant GM-CSF. MALIK, S. T. A., MARTIN, D., HART, I., and BALKVVILL, F., Br. J. Cancer, 1991, 63,(3), 399–403.
  • Prolonged-release terbutaline sulfate microcapsules. MANliKAR, N. C., PURANIK, P. K., and Jostii, S. B., J. Microencapsulation, 1991, 8, (4), 521–523.
  • Liposomal drug delivery thermodynamic and chemical kinetic considerations. MARGALIT, R., ALON, R., LINENI3ERG, M., RUBIN, I., ROSEMAN, T. J., and WOOD, R. W., J. Controlled Release, 1991, 17, (3), 285–296.
  • Liposomal delivery of purified heat shock protein hsp70 into rat pancreatic islets as protection against interleukin 1 beta-induced impaired beta-cell function. MARGULIS, B. A., SANDLER, S., EIZIRIK, D. L., WELSH, N., and WELSH, M., Diabetes, 1991, 40, (11), 1418–1422.
  • Effect of molecular weight in amphipathic polyethyleneglycol on prolonging the circulation time of large unilamellar liposomes. MARUYAMA, K., YUDA, T., OxAmoTo, A., ISHIKURA, C., KOJIMA, S., and IWATSURU, M., Chem. Pharm. Bull., 1991, 39, (6), 1620–1622.
  • Drug delivery by organ-specific immunoliposomes. MARUYAMA, K., Mom, A., KENNEL, S. J., WAALKES, M. V. B., SCHERPHOF, G. L., and HUANG, L., ACS Symp. Ser., 1991, 469 (Polym. Drugs Drug Delivery Syst.), 275–284.
  • Nebulization of the polylactic acid microspheres from aqueous suspension. MASINDE, L., and HICKEY, A. J., Pharm. Res., 1991, 8, (10, Suppl.), S120.
  • pH-Dependent lipid packing, membrane permeability and fusion in phosphatidylcholine vesicles. MASSARI, S., FOI,ENA, E., AMBROSIN, V., SCHIAVO, G., and COLONNA, R., Biochim. Biophys. Acta, 1991, 1067, (2), 131–138.
  • Cationic liposomes enable bovine herpesvirus type 2 DNA to infect cells (letter). MAY, J. T., JARDINE, D., and KYRIAZIS, A., Acta Viral. (Praha), 1991, 35, (1), 107.
  • A comparative study of the bronchodilator effect and duration of action of liposome-encapsulated beta 2-adrenergic agonists in the guinea pig. MCCALDEN, T. A., and RADHAKRISHNAN, R., Pulm. Pharmacol., 1991, 4, (3), 140–145.
  • Formation of polymeric microspheres using electron beam radiation. MCHERRON, D. C., and WILKES, G. L., J. Appl. Polym. Sci., 1991, 43, (6), 1045–1058.
  • Liposomal hamycin: reduced toxicity and improved antifungal efficacy in vitro and in vivo. MEHTA, R. T., MCQUEEN, T. J., KEYHANI, A., and LOPEZ-BERESTEIN, G., J. Infect. Dis., 1991, 164, (5), 1003–1006.
  • Interaction of ubiquinone and strophanthin in liposomes. MECNILK, I. Yu, GORYUSHKO, G. G., and SACHENKO, L. G., Farm. Zh. (Kiev), 1991, (5), 73–74.
  • In vitro evaluation of the association of thermosensitive liposome-encapsulated doxorubicin with hyperthermia. MERLIN, J. L., Eur. J. Cancer, 1991, 27, (8), 1031–1034.
  • Encapsulation of doxonthicin in thermosensitive small unilamellar vesicle liposomes. MERLIN, J. L., Eur. J. Cancer, 1991, 27, (8), 1026–1030.
  • Liposomal amphotericin B (ambisome): safety data from a Phase II-III clinical trial. MEUNIER, F., PRENTICE, H. G., and RINGDEN, 0., J. Antimicrob. Chemother., 1991, 28, (Suppl. B), 83–92. Tertiary amines increase liposome permeability to hydrogen ions. An ESR study. MIHAILESCU, D., CONSTANTINESCU, A., TATAR, L., IoNEscu, M. S., and FRANGOPOI., P. T., Rev. Roum. Biochim., 1991, 28, (1–2), 49–55.
  • Poly RI poly RC into pH-sensitive liposomes dramatically enhances interferon production on L929 and HeLa cells. MILHAUD, P. G., COMPAGNON, B., and PHILIPPOT, J. R., J. Interferon Res., 1991, 11, (Suppl. 1), S141.
  • Free and liposome-encapsulated double-stranded RNAs as inducers of interferon, interleukin-6, and cellular toxicity. MILHAUD, P. G., MACHY, P., COLOTE, S., LEBLEU, B., and LESERMAN, L., J. Interferon Res., 1991, 11, (5), 261–265.
  • Development of poly(L-lactic acid) microspheres containing tetracycline for periodontal therapy. MINABE, M., IIDA, M., TAKEUCHI, K., Horn, T., HYON-SONG-HYU, and IKADA, Y., Drug Delivery Syst., 1991, 6, (3), 201–205.
  • Laser manipulation and ablation of a single microcapsule in water. M I SAWA, H., KITAMURA, N., and MASUHARA, H., J. Am. Chem. Soc., 1991, 113, (21), 7859–7863.
  • Lipid peroxidation of lecithin liposomes depressed by some constituents of propolis. Misic, V., ONDRIAS, K., GERGEL, D., BULLOVA, D., SUCHY, V., and NAGY, M., Fitoterapia, 1991,62, (3), 215–220.
  • Growth inhibition of glioma cells of different cell lines by human interferon-beta produced in the cells transfected with its gene by means of liposomes. MtzuNo, M., YOSHIDA, J., SUGITA, K., and YAGI, K., J. Clin. Biochem. Nutr., 1990, 9, (2), 73–77.
  • Lipid microspheres and lecithinized-polymer drug delivery systems. MIZUSHIMA, Y., and
  • IGARASHI, R., ACS Symp. Ser., 1991, 469, (Polym. Drugs Drug Delivery Syst.), 266–274. Nonsolvent effects of ethylcellulose microcapsules. MOI,DENHAUER, M. G., and NAIRN, J. G., Pharm. Res., 1991, 8, (10, Suppl.), S148.
  • The effect of rate of evaporation on the coat structure of ethyl cellulose microcapsules. MOI,DENHAUER, M. G., and NAIRN, J. G., J. Controlled Release, 1991, 17, (1), 49–60.
  • Estimation of the size of liposomes by modified HDC. MOLINA, F. J., VILA, A. 0., LLACER, C., MARTOS, M. J., and FIGUERUELO, J. E., J. High Resolut. Chromatogr., 1991, 14, (9), 590–592.
  • Polyacrylic microspheres as a solid phase for microparticle-enhanced nephelometric im-munoassay (NEPHELIA) of transferrin. MONTAGNE, P., LAROCHE, P., CUILLIERE, M. L., RIOCHET, D., FLECHEUX, 0., VARCIN, P., MARCHAND, J., PAU, B., and DUHEILLE, J., J. Immunoassay, 1991, 12, (2), 165–183.
  • Controlled release microspheres based on Eudragit L100 for the oral administration of erythromycin. MORISHITA, I., MORISHITA, M., MACHIDA, Y., and NAGAI, T., Drug Des. Deliv., 1991, 7, (4), 309–319.
  • One-step purification of Escherichia coil hydrogen ion ATPase (F0F1) and its reconstitution into liposomes with neurotransmitter transporters. MORIVAMA, Y., IWAMOTO, A., HANADA, H., MAEDA, M., and FUTAI, M., J. Biol. Chem., 1991, 266, (33), 22141–22146.
  • Computation of release kinetics of isoniazid microcapsules. MUYIURI, G., and PAL, T. K., Boll. Chim. Farm., 1991, 130, (5), 169–171.
  • The effect of block co-polymers on the uptake of model polystyrene microspheres by kupffer cells: in vitro and in vivo studies. MUIR, I. S., MOGHIMI, S. M., ILLUM, L., DAVIS, S. S., and DAVIES, M. C., Biochem. Soc. Trans., 1991, 19, (3), 329S.
  • Neutron-activated holmium-166-poly(L-lactic acid) microspheres: a potential agent for the internal radiation therapy of hepatic tumors. MUMPER, R. J., RYO, U. Y., and JAY, M., J. Nucl. Med., 1991, 32, (11), 2139–2143.
  • Interaction of cells from murine organs with liposomes of various composition. MUZIA, G. I., GRABAREVA, L. P., DMITRIEVA, L. N., KASHKIN, K. P., and KULIKOV, V. I., Biokhimiia, 1991, 56, (7), 1215–1219.
  • Liposomes as carriers for antibiotics. NACUCCHIO, M. C., DI Rocco, P. H., and SORDELLI, D. 0., Targeted Diagn. Ther., 1990, 3, 337–354.
  • Effect of inserted bacteriohopan-32-ol on the stability of liposomal membranes. NAGUMO, A., TAKANASH1, K., and SUZUKI, Y., Chem. Pharm. Bull., 1991, 39, (7), 1889–1891.
  • Application of biodegradable microspheres to hepatitis B surface antigen vaccination system.
  • NELLORE, R., Auujn, P., and BHAGAT, H. R., Pharm. Res., 1991, 8, (10, Suppl.), S151. Liposomes: a practical approach. NEW, R. R. C., (Ed.). IRL Press, Oxford, UK, 1990, 301 pp. Carboxyacyl derivatives of cardiolipin as four-tailed hydrophilic anchors for the covalent coupling of hydrophilic proteins to liposomes. NIEDERMANN, G., WEISSIG, V., STERNBERG, B., and LASCH, J., Biol. Chem. Hoppe Seyler, 1991, 372, (9), 721.
  • Optimization of the liposomes encapsulating a new lipopeptide CGP 31362 for efficient activation of tumoricidal properties in monocytes and macrophages. Nit, A., UTSUG1, T., FAN, D., DENKINS, Y., PAK, C., BROWN, D., VAN HOOGEVEST, P., and FIDLER, I. J., J. Immunother, 1991, 10, (4), 236–246.
  • Cholesterol sulfate-containing liposomes entrapping adriamycin. Pharmacokinetics, and antineoplastic effect. NODA, H., OGASAWARA, T., YAMAKAWA, H., IinA, T., KURONO, M., and YAGI, K., J. Clin. Biochem. Nutr., 1991, 10, (3), 181–188.
  • Preparation and some properties of cholesterol sulfate-containing liposomes entrapping adriamycin. NODA, H., OGASAWARA, T., YAMAKAWA, H., IIDA, T., KuRONO, M., and YAGI, K., J. Clin. Biochem. Nutr., 1991, 10, (2), 83–91.
  • Priming for in vitro and in vivo anti-human T lymphotropic virus type 1 cellular immunity by virus-related protein reconstituted into liposome. NOGUCHI, Y., NonucHi, T., SATO, T., YOK00, Y., IToui, S., YOSHIDA, M., YOSHIKA, T., AKIYOSHI, K., SUNAMOTO, J., etal., J. Immunol., 1991, 146, (10), 3599–3603.
  • Preparation and evaluation of biodegradable thermoresponsive microspheres. NOZAWA, I., SUZUKI, Y., SATO, S., JUNI, K., SUGIBAYASHI, K., and MORIMOTO, Y., J. Controlled Release, 1991, 17, (1), 33–39.
  • Effects of gelatin-acacia microcapsule and algal meal supplementation of algal diets on growth rates of Sydney rock oyster, Saccostrea commercialis (Iredale and Roughley), larvae. NUMAGUCHI, K., and NELL, J. A., Aquaculture, 1991, 94, (1), 65–78.
  • Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclo-phosphamide, monoclonal antibodies, and magnetic microspheres. O'BRIANT, K. C., SHPAI.I., E. J., HOUSTON, L. L., PETERS, W. P., and BAST, R. C. JR, Cancer, 1991, 68, (6), 1272–1278.
  • Preparation and characterization of polymer-coated small unilamellar vesicles. OEZDEN, M. Y., and HASIRCI, V. N., Biochim. Biophys. Acta, 1991, 1075, (1), 102–108.
  • Microcapsule DDS (drug delivery system) using biodegradable polymers. OGAWA, Y., Drug Delivery Syst., 1991, 6, (3), 165–170.
  • Formulation factors affecting the efficacy phytotoxicity and rainfastness of fenitrothion microcapsules for agricultural use. OHTSUBO, T., TSUDA, S., TAKEDA, H., and Tsuji, K., J. Pestic. Sci., 1991, 16, (4), 609–614.
  • Formulation factors of pyrethroid microcapsules affecting rainfastness, phytotoxicity, and mammalian toxicity. OHTSUBO, T., TAKEDA, H., TSUDA, S., and Tsuji, K., Nippon Noyaku Gakkaishi, 1991, 16, (3), 413–418.
  • A study of the physical strength of fenitrothion microcapsules. OHTSUBO, T., TSUDA, S., and Tsuji, K., Polymer, 1991, 32, (13), 2395–2399.
  • Growth inhibition of tumour cells by a liposome-encapsulated mycolic acid-containing glycolipid trehalose 2,3,6"-trimycolate. OHTSUBO, Y., FURUKAWA, M., IMAGAWA, T., GRAMMER, J. R., BAKER, C. D., ROUBIN, G. S., and BOOYSE, F., Circulation, 1991, 84, (4, Suppl. 1991, 74, (3), 497–503.
  • Preparation of albumin microsphere-grafted galactose residues through polyethylene glycol spacers, release behavior of 5-fluorouracil from them, and their lectin-mediated aggregation. OHYA, Y., TAKEI, T., FUKUSHIMA, H., and OUCH, T., J. Macromol. Sci. Chem., 1991, A28, (8), 743–760.
  • Effect of liposome-entrapped lidocaine on limbic status epilepticus in rats. OKA, M., KUROKOUCHI, A., MOB, N., KUMASHIRO, H., and OHNO, E., No To Shinkei, 1991, 43, (8), 769–773.
  • A new concept for interpretation of first-order release from albumin microspheres. OKADA, J., ASANO, S., and KONDO, T., J. Microencapsulation, 1991, 8, (4), 483–496.
  • A fundamental study of preparation of liposomes containing ferromagnetic particles. OKAZAKI, M., Tsuji, M., OGUCHI, K., ARAI, H., KAMICHI, 1., Suzum, S., ARAI, K., and KOIKE, T., Showa Univ. J. Med. Sci., 1991, 3, (1), 1–9.
  • Coating of certain matrix cores with aqueous-based systems of acrylate methacrylate, a water-insoluble copolymer and drug release profiles. OKOR, R. S., OTIMENYIN, S., and IjEn, I., J. Controlled Release, 1991, 16, (3), 349–353.
  • Immunoactivity of anti-bovine serum albumin antibody adsorbed on polymer microspheres having heterogeneous surfaces consisting of hydrophilic and hydrophobic parts. OKUBO, M., YAMAMOTO, Y., UNo, M., and KAMEI, S., Chem. Express, 1991, 6, (8), 623–626.
  • Production and extractive biocatalysis of ethanol using microencapsulated yeast cells and lipase system. OLIVEIRA, A. C., and CABRAL, J. M. S., J. Chem. Technol. Biotechnol., 1991,52, (2), 219–225.
  • Microencapsulation of pheromone analogue and measurement of the sustained release. ON, S., UMEKI, N., MOHRI, H., and Iso, M., J. Microencapsulation, 1991, 8, (4), 465–478.
  • Comparison of dynamics of lecithin liposomes and brain total lipid liposomes with synap-tosomal membranes: an EPR spectroscopy study. ONDRIAS, K., STASKO, A., Misix, V., and SVAJDLENKA, E., Gen. Physiol. Biophys., 1991, 10, (4), 411–420.
  • Sensitization of multidrug-resistant colon cancer cells to doxorubicin encapsulated in liposomes. OUDARD, S., THIERRY, A., JORGENSEN, T. J., and RAHMAN, A., Cancer Chemother. Pharmacol., 1991, 28, (4), 259–265.
  • Preparation and characterization of polymer coated small unilamellar vesicles. OZDEN, M. Y., and HASIRCI, V. N., Bioclum. Biophys. Acta, 1991, 1075, (1), 102–108.
  • Stabilization of liposomes with collagen. PAJEAN, M., Huc, A., and HERBAGE, D., Int. J. Pharm., 1991, 77, (1), 31–40.
  • Liposomal delivery of biological response modifiers to macrophages. PAK, C. C., and FIDLER, I. J., Biotherapy, 1991, 3, (1), 55–64.
  • Studies of 5-fluorouracil nanocapsules. PAN, W. S., and Hu, J., Yao Hsueh Hsueh Pao, 1991, 26, (4), 280–285.
  • Methyl ketone production in milk-fat-coated microcapsules 2. Methyl ketones from controlled concentrations of free fatty acids. PANNELL, L. K., and OLSON, N. F., J. Dairy Sci., 1991, 74, (7), 2054–2059.
  • Methyl ketone production in milk-fat-coated microcapsules. 1. Variation of lipase and spore concentrations. PANNELL. L. K., and OLSEN, N. F., J. Diary Sci., 1991, 74, (7), 2048–2053.
  • Inhibition of platelet adhesion by platelet-derived liposomes. PARKS, J. M., HADDOCK, R. C., GRAMMER, J. R., BAKER, C. D., ROUBIN, G. S., and BOOYSE, F., Circulation, 1991,84, (4, Suppl. 2), 11122.
  • Retention of protein bioactivity in microencapsulated toxins derived from Bacillus thuringiensis. PATEL, P. R., SPEAKER, T. J., and CHANG, F., Pharnz. Res., 1991, 8, (10, Suppl.), S151. Microspheres: technological aspects and pharmaceutical applications. PENA, M. B., MARTINEZ, B. G., and NACUCCHIO, M. C., Acta Farm. Bonaerense, 1990, 9, (1), 53–64.
  • Development of new beta-emitting microcapsules for tumor selective radiotherapy. PERDRISOT, R., LE-JEUNE, J. J., CHOTARD, D., POULIQUEN, D., BEAU, P., LEPAPE, A., and JALLET, P., Eur. L. Nucl. Med., 1991, 18, (8), 634.
  • Pharmacologic studies with new liposome-entrapped cisplatin derivatives. PEREZ-SOLER, R., SIDDIK, Z. H., FRANCIS, K., AL-BAKER, S., KRAKOFF, I. H., and KHOKHAR, A. R., Cancer Drug Des., 1991, 6, (4), 296.
  • Hypoglycemic response of diabetic rats to insulin-liposomes. PETKOWICZ, J., BYRA, A., and Szummo, T., Acta Physiol. Pol., 1990, 41, (1-3), 97–103.
  • Liposomes as antitumor drug carriers. Part I. Preparation of liposomal farmorubicin. PETKOWICZ, J., and Woisici, T., Farm. Pol., 1990, 46, (3–4), 79–83.
  • Ischemiaireperfusion-induced changes in membrane fluidity characteristics of brain capil-lary endothelial cells and its prevention by liposomal-incorporated superoxide dis-mutase. PHELAN, A. M., and LANGE, D. G., Biochim. Biophys. Acta, 1991, 1067, (1), 97–102.
  • Immunogenicity of immunoliposomes. Pfiii.ors, N. C., and Ennio, A., Immunol. Lett., 1991, 30, (3), 291–296.
  • Liposomal encapsulation of 3'-azido-3'-deoxythymidine (AZT) results in decreased bone marrow toxicity and enhanced activity against murine AIDS-induced immunosup-pression. PHILLIPS, N. C., SKAMENE, E., and TSOUKAS, C., J. Acquired Immune Defic. Syndr., 1991, 4, (10), 959–966.
  • Thermodynamical characteristics and volume compressibility of dipalmitoylphosphatidyl-choline liposomes containing bacteriorhodopsin. PIKNOVA, B., HIANIK, T., SHESTIMIROV, V. N., and SHNYROV, V. L., Gen. Physiol. Biophys., 1991, 10, (4), 395–410.
  • Pharmacodynamic evaluation of liposomally encapsulated doxorubicin TLC D-99. PILKIEWICZ, F. G., OsTRo, M. J., MAYER, L. D., CULL'S, P. R., and BALLY, M. B., Cancer Invest, 1991, 9,(3), 349.
  • An in vitro comparative evaluation of microencapsulated pancreatic enzyme preparations. PI.AKUNOV-MORAN, I., THOMAS, A., and FATMI, A., Pharm. Res., 1991, 8, (10, Suppl.) S38.
  • Local delivery of liposome-encapsulated proline analog prevents pulmonary hypertension in the rat. POIANI, 0. J., SUMKA, J. M., Tozzi, C. A., LIAO WE CHI, and RILEY, D. J., Amino Acids: Chem. Biol. Med. (Pap. Int. Congr. Amino Acid Res.), ESCOM, 1989, Leiden, Neth, 1990, pp. 634–642. Eds: G. Lubec and G. A. Rosenthal.
  • Influence of stabilizers on particle size and polydispersity of polybutyl and polyisobutyl cyanoacrylate nanoparticles. PONS, M., GARCIA, M. L., and VALLS, 0., Colloid Polym. Sci., 1991, 269, (8), 855–858.
  • Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism. POULIQUEN, D., LE JEUNE, J. J., PERDRISOT, R., ERMIAS, A., and JALLET, P., Magn. Reson. Imaging, 1991, 9, (3), 275–283.
  • Synthesis of aminoethyl methacrylate microsphere methotrexate conjugate and its applic-ations in tumor cytotoxicity studies. POURFARZIB, R., and D'SOUZA, M., Pharm. Res., 1991, 8, (10, Suppl.), S147.
  • Antimicrobial activity of cephaloridine in the presence of crude and purified preparations of bacterial beta-lactamases before and after liposome encapsulation. POURKAVOOS, N., Pharm. Res., 1991, 8, (10, Suppl.), S214.
  • Pharmacology and toxicology of a liposomal formulation of amphotericin B (ambisome) in rodents. PROFFITT, R. T., SATORIUS, A., CHIANG, S. M., SULLIVAN, L., and ADI.ER-MOORE, J. P., J. Antimicrob. Chemother., 1991, 28, (Suppl. B), 49–62.
  • Study of abietic acid glycerol derivatives as microencapsulating materials. PURANIK, P. K., and DORLE, A. K., J. Microencapsulation, 1991, 8, (2), 247–252.
  • Liposomes in dermatology and cosmetics-hopes and reality. RAAB, W., Pharm. Ztg., 1991, 136, (32), 9–14. 16, 18, 21, 24.
  • Liposomal amphotericin B: an effective, nontoxic preparation for the treatment of urinary tract infections caused by Candida albicans. RALPH, E. D., BARBER, K. R., and GRANT, C. W., Am. J. Nephrol., 1991, 11, (2), 118–122.
  • Characterization of biodegradable microspheres containing dehydroisoandrosterone. RAMTOOLA, Z., CORRIGAN, 0. I., and BOURKE, E., Drug Dev. Ind. Pharm., 1991, 17, (13), 1857–1873.
  • Preparation and characterization of polymerized protovesicles. REBOIRAS, M. D., and JONES, M. N., Colloids Surf., 1991, 57, (1-2), 197–204.
  • Studies on the mechanism of the hematoporphyrin-sensitized photooxidation of 1,3-diphenyl-isobenzofuran in ethanol and unilamellar liposomes. REDD, E., VAI.DLIGA, G., RODGERS, M. A. J., and JOB, G., Photochem. Photobiol., 1991, 54, (4), 633–637.
  • pH Sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein. REDDY, R., ZHOU, F., HUANG, L., CARBONE, F., BEVAN, M., and ROUSE, B. T., J. Immunol. Methods, 1991, 141, (2), 157–163.
  • Interaction of liposomes with the binary system SDS/alkylamidobetaine. RIBOSA, 1., GARCIA, M. T., DE LA MAZA, A., BALAGUER, F., TRULLAS, C., and COLL, J., COMUn. JOrn. Corn. Esp. Deterg., 1991, 22, 173–191.
  • Efficacy of amphotericin B encapsulated in liposomes (ambisome) in the treatment of invasive fungal infections in immunocompromised patients. Rim-ADEN, 0., MEUNIER, F., TOLLEMAR, J., RICCI, P., TURA, S., KUSE, E., VIVIANI, M. A., GORIN, N. C., KLASTERSKY, J. et al. J. Antimicrob. Chemother., 1991, 28, (Suppl. B), 73–82.
  • Separation of free from liposomal gentamicin in plasma and analysis of the behavior of TLC-G-65 in vitro and in vivo. ROBEETS, P., PALAITIS, W., PILKIEWICZ, F., and SWENSON, C. E., Thirty-first Interseience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, USA, 29 September-2 October 1991. Program Abstr., 1991, 31, 124.
  • Control of skin humidity with liposomes. Stabilization of skin-care oils and lipophilic active substances with liposomes. ROEDING, J., and GHYCZY. M., Set:fen. Oele, Fette, Wachse, 1991, 117, (10), 372–378.
  • Staphylococci surviving intracellularly in phagocytes from patients suffering from chronic granulomatous disease are killed in vitro by antibiotics encapsulated in liposome. ROESLER, J., FIOCKERTZ, S., VOGT, B., and LOHMANN-MATTHES, M. L., J. Clin. Invest., 1991, 88, (4), 1224–1229.
  • Liposomes labelled with anti-CEA and CA 19–9: effectiveness in vivo as carriers for radioiso-topes. ROMBI, G. P., Cossu, F., and MELIE, G., Eur. J. Cancer, 1991, 27, (Suppl. 3), S84.
  • Crosslinked, degradable starch microspheres as carriers of paramagnetic contrast agents for magnetic resonance imaging: synthesis, degradation, and relaxation properties.
  • RONGVED, P., LINDBERG, B., and KLAVENESS, J., Carbohydr. Res., 1991, 214, (2), 325–330.
  • An evaluation of phase change microcapsules for use in enhanced heat transfer fluids. ROY, S. K., and SENGUPTA, S., Int. Commun. Heat Mass Transfer, 1991, 18, (4), 495–507.
  • In vivo biodistribution of a radiolabeled blood substitute: 99mTc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit. RUDOLPH, A. S., KLIPPER, R. W., GoiNs, B., and PHILLIPS, W. T., Proc. Natl. Acad. Sci. USA, 1991, 88, (23), 10976–10980.
  • Core-shell type polymer microspheres prepared from poly(styrene-b-methacrylic acid). 1. Synthesis of microgel. SAITO, R., KOTSUBO, H., and ISHIZU, K., Eur. Polym. J., 1991, 27, (10), 1153–1159.
  • The interaction of liposomal valinomycin and cisplatin in human ovarian carcinoma cells. SAKATA, M. J., and DAOUD, S. S., Cancer Drug Des., 1991, 6, (4), 286.
  • Interaction of the 140/130/110 kDa rhoptry protein complex of Plasmodium falciparum with the erythrocyte membrane and liposomes. SAM-YEI.LOWE-TOBILI, Y., and PERKINS, M. E., Exp. Parasitol., 1991, 73, (2), 161–171.
  • Contrast opacification of left ventricular myocardium following intravenous administration of sonicated albumin microspheres. SANDERS, W. E. JR, CHEIRIF, J., DESIR, R., ZOGHBI, W. A., HOYT, B. D., Scuurz, P. E., and QUINONES, M. A., Am. Heart J., 1991, 122, (6), 1660–1665.
  • Phase diagram studies of microcapsule formation using hydroxypropyl methylcellulose phthalate. SANGHVI, S. P., GARCIA-ENCINA, G., and NAIRN, J. G., Pharm. Res., 1991, 8, (10, Suppl.), S148.
  • Control of microcapsule particle size using different polymer of solvent ratios with cellulose acetate trimellitate. SANGHVI, S. P., and NAIRN, J. G., Pharm. Res., 1991,8, (10, Suppl.), S148. Ocular drug delivery system using liposomes. SARKAR, R. P., AHMED, I., and ACE, L. N., Pharm.
  • Res., 1991, 8, (10, Suppl.), S153.
  • Immunotherapeutic effects of autologous liposome-borne tumor-specific transplantation antigens in combination with cyclophosphamide on postsurgical tumor recurrence in mice. SATO, T., SATO, N., Kmucut, K., HIRATA, K., and LEGRUE, S. J., Tumor Res., 1990, 25, 21–35.
  • Photochemically controlled ion permeability of liposomal membranes containing amphiphi-lic azobenzene. SATO, T., KiJImA, M., SHIGA, Y., and YONEZAWA, Y., Langmuir, 1991, 7, (10), 2330–2335.
  • Af-R1 pilus protein remains immunogenic to rabbit spleen cells immunized in vitro after microencapsulation. SAU, K., REID, R. H., DAVIS, D., BOEDEKER, E. C., NEI.LORE, R., and BHAGAT, H. R., Pharm. Res., 1991, 8, (10, Suppl.), S164.
  • Infective endocarditis-the effect of liposomes as carrier substance for alpha 1-antitrypsin and ampicillin. SCHAAF, H. S., BATES, W. D., HANEKOM, C., NEITELER, B. F., KRIEGLER, A. B., and VAN DER MERWE, P. L., SAMJ, 1991, 79, (10), 588–590.
  • Sensitization in vitro of human peripheral blood mononuclear cells to phenolic glycolipid 1 of Mycobacterium leprae in liposomes. SCHAUF, V., HOLOBAUGH, P., MILLER, P., and MITTAI., K., Cell Immunol., 1991, 137, (1), 81–87.
  • Liposome-mediated enzymatic synthesis of phosphatidylcholine as an approach to self-replicating liposomes. SCHMIDI.I, P. K., SCHURTENBERGER, P., and LuIsi, P. L., J. Am. Chem. Soc., 1991, 113, (21), 8127–8130.
  • Directed lysis of experimental cancer by beta-carotene in liposomes. SCHWARTZ, J. L., FLYNN, E., TRICKLER, D., and SHKLAR, G., Nutr. Cancer, 1991, 16, (2), 107–124.
  • Dielectric analysis of PMMA microcapsules containing an aqueous potassium chloride solution to derive a distribution function of the release rate of potassium chloride. SEKINE, K., and HANAI, T., Colloid Polym. Sci., 1991, 269, (9), 880–888.
  • Wax microspheres as carriers for anti-inflammatory drugs. SEPULVEDA, S., and GHALY, E. S., Pharm. Res., 1991, 8, (10, Suppl.), S114.
  • Development of a microencapsulated odor detection test. SERBY, M., KALKSTEIN, D., and LARSON, P., Chem. Senses, 1991, 16, (5), 579.
  • Peptide synthesis by microencapsulated chymotrypsin. SERRALHEIRO, M. L., EMPIS, J. M., and CABRAL, J. M. S., Ann. NY Acad. Sci., 1990, 613, (Enzyme Eng. 10), 638–642.
  • Preparation of substained release microcapsules containing sparingly-soluble salts of drugs. SHAH, K. P., and CHAFETZ, L., Pharm. Res., 1991, 8, (10, Suppl.), S126.
  • Biexponential release kinetics of cliltiazem pectate loaded microcapsules. SHAH, K. P., and CHAFETZ, L., Pharm. Res., 1991, 8, (10, Suppl.), S113.
  • Encapsulation of the pre-formed cooked cured-meat pigment. J. Food Sci., 1991, 56, (6), 1500–1504.
  • A preliminary study on liposome encapsulated human interferon-alpha by resisting trypsin digestion in vitro. SHAN FENGPING and LIANG ZAIFU. Zhongguo Yike Daxue Xuebao, 1990, 19(Zengkan), 22–24.
  • Microcapsules through polymer complexation. II. By complex coacervation of polymers containing a low charge density. SHAO, W., YIN, X., STEVENSON, W. T. K., and ALEXANDER, H., Biomaterials, 1991, 12, (5), 479–488.
  • Carrier-based delivery of n-phosphonacetyl-L-aspartic acid to human ovarian cancer cells in vitro studies. SHARMA, A., STRAUBINGER, N. L., and STRAUBINGER, R. M., Pharm. Res., 1991,8, (10, Suppl.), S196.
  • Studies on spray-dried microcapsules of ginger, basil and garlic essential oils for their preparations and properties. SHEEN, L. Y., and TSAI, S. J., J. Chin. Agric. Chem. Soc., 1991, 29, (2), 226–237.
  • Release kinetics of drugs from rosin-glycerol ester microcapsules prepared by solvent evaporation technique. SHEOREY, D. S., and DORI.E, A. K., J. Microencapsulation, 1991,8, (2), 243–246.
  • Study of some improved shellac derivatives as microencapsulating materials. SHEOREY, D. S., KSHIRSAGAR, M. D., and DORI.E, A. K., J. Microencapsulation, 1991, 8, (3), 375–380.
  • A new technique for the encapsulation of water-insoluble drugs using ethyl cellulose. SHEOREY, D. S., SA', M. S., and DORI.E, A. K., J. Microencapsulation, 1991, 8, (3), 359–368.
  • Prolongation of drug release by covalent bonding of drugs to serum albumin microbeads.
  • SHEU, M. T., Ltu, C. H., and SoKowsxt, T. D., Drug Des. Deliv., 1991, (4), 251–257. Improving culture viability in frozen dairy desserts by microencapsulation. SHEU, T. Y., and
  • MARSHALL, R. T., J. Dairy Sci., 1991, 74, (Suppl. I), 107.
  • Induction of in vitro and in vivo anti-tumor responses by sensitization of mice with liposomes containing a crude butanol extract of leukemia cells and transferred inter-membranously with cell-surface proteins. SHIBATA, R., NOGUCHI, T., SATO, T., AKIYOSHI, K., SUNAMOTO, J., SHIKU, H., and NAKAYAMA, E., Int. J. Cancer, 1991, 48, (3), 434–442.
  • Semi-permeable microcapsules for cell culture: ultra-structural characterization. SHIMA, S. M., NEWMAN, E. L., HOPWOOD, D., and CusHIERI, A., J. Microencapsulation, 1991, 8,(3), 307–316.
  • Effect of drug loading and molecular weight of cellulose acetate propionate on the release characteristics of theophylline microspheres. SHUKLA, A., and PRICE, J. C., Pharm. Res., 1991, 8, (11), 1396–1400.
  • Clinical pharmacokinetics of liposome-entrapped cis-bis-neodecanoato- trans-R,R-1,2-diaminocyclohexaneplatinum(H) (L-NDDP) administered by hepatic arterial infusion. SIDDIK, Z. H., PEREZ-SOLER, R., KHOKHAR, A. R., PAZDUR, R., ROH, M. S., FRANCIS, K., CHASE, J., and KRAKOFF, I. H., Cancer Drug Des., 1991, 6, (4), 283–284.
  • Temperature induced changes in monomer-dimer distribution of merocyanine 540 in dimyristoyl lecithin liposomes. SIKUROVA, L., and FRANKOVA, R., Stud. Biophys., 1991, 140, (I), 21–28.
  • ESR study of the influence of gramicidin on egg lecithin liposome structure. SIKUROVA, L., KUBIZNOVA, A., and CHOMUTOV, G. B., Acta Phys. Univ. Comenianae, 1991, 32, 89–96.
  • Biodistribution and immune effects of liposome encapsulated interleukin-2 (IL-2). SILVER, H. K. B., WEE, R. K. H., KONG, S., BALI.Y, M., and MADDEN, T., Eur. J. Cancer, 1991, 27, (Suppl. 3), S57.
  • Controlled delivery of diphtheria toxoid using biodegradable poly(D, L-lactide) microcapsules. SINGH, M., SINGH, A., and TALWAR, G. P., Pharm. Res., 1991, 8, (7), 958–961.
  • Controlled release of LH-RH-DT from bioerodible hydrogel microspheres. SINGH, M., RATHI, R., SINGH, A., HELLER, J., TALWAR, G. P., and KOPECEK, J., Int. J. Pharm., 1991, 76,(3), R5-R8. A stable albumin acacia coacervate microencapsulation system. SINGH, 0. N., and BURGESS, D.
  • J., Pharm. Res., 1991, 8, (10, Suppl.), S164.
  • Liposomal amphotericin B and erythrocyte echinocytosis (letter). Sm tru, 0. P., and PRENTICE, H. G., Bone Marrow Transplant, 1991, 8, (2), 155–156.
  • Phase behavior and structure in the soybean phosphatidylcholine-ethanol-water system. SOEDERBERG, I., Prog. Colloid Polym. Sci., 1990,82 (Surfactants Macromol. : Self-A ssem. Interfaces Bulk), 285–289.
  • Formulation of 5-fluorouracil microspheres for site specific drug delivery systems. SONAVARIA, V. J., JAMBHEKAR, S., WILLIAMS, D., MENDES, R., and TABIBI, E., Pharm. Res., 1991, 8, (10, Suppl.), S149.
  • Study of the dependence of the permeability of phosphatidylcholine liposomes for glucose on their prostaglandin level. SOROKINA, A. D., IANOPOL'SKAIA, N. D., VIBAS, I. M., IAILENKO, T. L., and VOGUSLAVSKII, L. I., Biokhimiia, 1991, 56, (4), 747–752.
  • Nanoparticles and liposomes: a state of the art. SPEISER, P. P., Methods Find. Exp. Clin. Pharmacol., 1991, 13, (5), 337–342.
  • Detoxification using microencapsulated enzymes: kinetic aspects. STANCE, J., STANCE, K., BRUEGMANN, E., DUMMLER, W., ERNST, B., FALKENHAGEN, D., and DAUTZENBERG, H., Int. J. Arti f. Organs, 1991, 14, (9), 585.
  • Lipoic acid derived polymerizable liposomes. STEFELY, J. S., Marquette Univ., Milwaukee, WI, USA, Dissertation, 1990, 350 pp.
  • Improved antitumor effect and increased side effects at combined hepatic arterial treatment with degradable starch microspheres and adriamycin or the nitrosoureas TCNU and BCNU in rats with a liver adenocarcinoma. STENRAM, U., JAKOBSSON, B., Roos, G., TEDER, H., and EL-HAG, I., Eur. J. Cancer, 1991, 27, (Suppl. 3), S57.
  • Biodegradable microspheres. XIII: immune response to the DNP hapten conjugated to polyacryl starch microparticles. STJAERNKVIST, P., DEGLING, L., and SJOEHOLM, I., J. Pharm. Sci., 1991, 80, (5), 436–440.
  • Liposomes and biotherapeutics. STORM, G., WiLms, H. P., and CROMMELIN, D. J. A., Biotherapy, 1991, 3, (1), 25–42.
  • Inhibition of immune reactions in vivo by liposome associated transforming growth factor TGF type beta-1. STRASSMAN, G., BERTOLINI, D. R., and EIDELMAN, 0., Clin. Exp. Immunol., 1991, 86, (3), 532–536.
  • Liposomes as cyclosporin a carriers: ESR study of cyclosporin a interaction with 1,2-dimyristoyl-SN-3-phosphatidylglycerol liposomes. STUHNE-SEKALEC, L., and STANACEV, N., J. Microencapsulation, 1991, 8, (4), 455–464.
  • Liposomes as carriers of macrolides: preferential association of erythromycin A and azithromycin with liposomes of phosphatidylglycerol containing unsaturated fatty acid(s). STUHNE-SEKALEC, L., STANACEV, N. Z., and DJOKIC, S., J. Microencapsulation, 1991, 8, (2), 171–183.
  • Liposomes as carriers of cyclosporin A. STUHNE-SEKALEC, L., and STANACEV, N. Z., J. Microen-capsulation, 1991, 8, (4), 441–446.
  • Liposomes as cyclosporin A carriers: the influence of ordering of hydrocarbon chains of phosphatidylglycerol liposomes on the association with and topography of cyclosporin A. STUHNE-SEKALEC, L., and STANACEV, N. Z., J. Microencapsulation, 1991, 8, (3), 283–294.
  • Studies on the degradation of chitosan and preparation of chitosan-alginate microcapsules. SUN DUOXIAN, ZHU YAN, DUNG ANJIE, GOOSEN, M. F. A., and SUN, A. M., C-MRS Int. Symp. Proc., 1990, North-Holland, Amsterdam, Neth, 1991, pp. 295–300. Eds: H. Feng, Y. Han and L. Huang.
  • Functionalization of artificial cell liposome and its application in biotechnology. SUNAMOTO, J., AKIYOSHI, K., SATO, T., SHIKU, I-I., HARA, K., and Koji, T., Kenkyu Hokoku-Asahi Garasu Zaidan, 1990, 57, 7–14.
  • Experimental studies on targeting chemotherapy using adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein monoclonal antibody. Suzum, H., Nippon Geka Gakkai Zasshi, 1991, 92, (3), 257–265.
  • Prospect for using liposomes in medical practice. SYNOVETS, 0. A., LAPSHIN, D. E., and RUDENKO, Yu. V., Vrach Delo, 1991, (6), 16–20.
  • Liposomal drug delivery current status and future prospects. SZOKA, F. C. JR, In: J. Wilschut and D. Hoekstra (Eds). Membrane Fusion. 902 pp. Marcel Dekker, New York, NY, USA; 1991, pp. 845–890.
  • Macrophage activation of antitumor function with biodegradable polymer microspheres. TABATA, Y., Seitai Zairyo, 1991, 9, (2), 81–93.
  • Electrostatic interaction of poly(L-lysine) with dipalmitoylphosphatidic acid studied by X-ray diffraction. TAKAHASHI, H., MATUOKA, S., KATO, S., OHKI, K., and HATTA, I., Biochim. Biophys. Acta, 1991, 1069, (2), 229–234.
  • Interfacial polymerization encapsulation of a viscous pigment mix: emulsification conditions and particle size distribution. TAN, H. S., NC, T. H., and MAHABADI, H. R., J. Microencapsul-ation, 1991, 8, (4), 525–536.
  • A simple method for coating of liposomes with proteins. TAN, L. S., and GREGORIADIS, G., Ann. Acad. Med. Singapore, 1990, 19, (6), 827–830.
  • Freeze-drying of liposomes prepared by sonication and extrusion techniques. TANAKA, K., TAKEDA, T., Fuji', K., and MIYAJIMA, K., Chem. Pharm. Bull., 1991, 39, (10), 2653–2656. Preparation of microcapsules containing water-absorbent polymer. TANAKA, M., SATO, K., and
  • KIMURA, I., Shikizai Kyokaishi, 1991, 64, (3), 140–147.
  • Antimicrobial action of p-hydoxybenzoic acid esters. V. Membrane disorders of Escherichia coli cells and liposomes induced by p-hydroxybenzoic acid ester. TATSUGUCHI, K., KUWAMOTO, S., OGOMORI, M., IDE, T., and WATANABE, T., Shokuhin Eiseigaku Zasshi, 1991, 32, (3), 121–127.
  • Tantalum-loaded polyurethane microspheres for particulate embolization: preparation and properties. THANOO, B. C., SUNNY, M. C., and JAYAKRISHNAN, A., Biomaterials, 1991, 12, (5), 525–528.
  • Localization of chromatophore proteins of Rhodobacter sphaeroides. I. Rapid calcium-induced fusion of chromatophores with phosphatidylglycerol liposomes for proteinase delivery to the luminal membrane surface. THEILER, R., and NIEDERMAN, R. A., J. Biol. Chem., 1991, 266, (34), 23157–23162.
  • Liposomal vaccine: influence of antigen association on the kinetics of the humoral response. THERIEN, H. M., LAIR, D., and SHAHUM, E., Vaccine, 1990, 8, (6), 558–567.
  • Liposome adjuvanticity: influence of dose and protein: lipid ratio on the humoral response to encapsulated and surface-linked antigen. THERIEN, H. M., SHAHUM, E., and FORTIN, A., Cell Immunol., 1991, 136, (2), 402–413.
  • Reconstitution of the tonoplast amino acid carrier into liposomes: evidence for an ATP-regulated carrier in different species. THUME, M., and DIETZ, K. J., Planta (Heidelb.) 1991, 185, (4), 569–575.
  • Electron microscopic studies of negatively stained liposomes and membrane intrinsic polypeptide. TICKNER, A. L., LEA, E. J. A., and HORNE, R. W., Micron. Microsc. Acta, 1990, 21, (1-2), 91–99.
  • Cyclophosphamide (CPM) liposome drug complexes. TODOROV, D., MANEVA, K., MICHAILOVA, S., GANCHEV, G., VASILEV, P., KAPOURDOV, V., and KATERINSKY, K., EU? • . J. Cancer, 1991,27, (Suppl. 3), S57.
  • Once-a-month injectable microcapsules of leuprorelin acetate. TOGUCHI, H., OGAWA, Y., OKADA, H., and YAMAMOTO, M., Yakugaku Zasshi, 1991, 111, (8), 397–409.
  • Formation of bioerodible polymeric microspheres and microparticles by rapid expansion of supercritical solutions. Tom, J. W., and DEBENEDETTI, P. G., Biotechnol. Prog., 1991, 7, (5), 403–411.
  • Therapeutic efficacy of liposome-encapsulated kanamycin against Mycobacterium intra-cellulare infection induced in mice. TOMIOKA, H., SAITO, H., SATO, K., and YONEYAMA, T., Am. Rev. Respir. Dis., 1991, 144, (3), 575–579.
  • Modification of estradiol percutaneous absorption by liposomal entrapment. TOULON, A., BESNARD, M., LECLERC, B., WEINGARTEN, C., SALIN-DROUIN, D., and COUARRAZE, G., STP Pharma Sci., 1991, 1, (1), 76–82.
  • Doxorubicin carried in nanospheres and the reversal of multidrug resistance in tumor cells. TREUPEL, L., POUPON, M. F., COUVREUR, P., and PUISIEUX, F., CR l'Academie Sc., Ser. III, 1991, 313, (3), 171–174.
  • Monoclonal antibodies, immunoconjugates, and liposomes as targeted therapeutic systems. TYLE, P., and RAM, B. P., Targeted Diagn. Ther., 1990, 3, 3–22.
  • Preparation of enteric-coated microspheres of Mycoplasma hyopneumoniae vaccine with cellulose acetate phthalate: the effect of swine serum on micromeritic properties. TZAN, Y. L., LIN, S. Y., WENG, C. N., and LEE, C. J., Biotechnol. Tech., 1991, 5, (2), 139–144.
  • Studies on temperature-sensitive liposome-encapsulated doxorubicin. UNEZAKI, S., MATSUMURA, M., OHTANI, Y., and TAKAHASHI, N., Byoin Yakugaku, 1991, 17, (3), 118–122.
  • A physicochemical study of the morphology of estrone microspheres. UPADRASFITA, S. M., PARIKH, B. V., NEAU, S. H., CUTRERA, M. A., and SILVEY, G. L., Pharm. Res., 1991, 8,(10, Suppl.), S105.
  • Comparative efficacy of liposomes containing synthetic bacterial cell wall analogs for tumoricidal activation of monocytes and macrophages. UTSUGI, T., Nil, A., FAN, D., PAK, C. C., DENKINS, Y., VAN-HOOGEVEST, P., and FIDLER, I. J., Cancer Immunol. Immunother., 1991, 33, (5), 285–292.
  • In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CGP 31362. UTSUGI, T., DINNEY, C. P. N., KILLION, J. J., and FIDLER, I. J., Cancer Immunol. Immunother., 1991, 33, (6), 375–381.
  • Tissue distribution and in vivo immunosuppressive activity of liposomal cyclosporine. VADIEI, K., LOPEZ-BERESTEIN, G., PEREZ-SOLER, R., and LUKE, D. R., Drug Metab. Dispos., 1991, 19,(6), 1147–1151.
  • Pharmacokinetics and tissue distribution of liposomal cis-bisneodecanoate-trans-R,R-1,2-diaminocyclohexaneplatinum(II) (L-NDDP) following single intravenous (IV) and intraperitoneal (IP) dose in the rat. VADIEI, K., SIDDIK, Z. H., KHOKHAR, A. R., and PEREZ-SOLER, R., Pharm. Res., 1991, 8, (10, Suppl.), S290.
  • Coacervation and complex coacervation. VAN OSS, C. J., Polym. Prepr. (Am. Chem. Soc. Div. Polym. Chem.), 1991, 32, (1), 598–599.
  • The molecular weight cut-off of alginate-polylysine microcapsules: reproducibility and influence of I.P. residence. VANDENBOSSCHE, G. M. R., and REMON, J. P., Int. J. Artif. Organs, 1991, 14, (9), 548.
  • Wettability studies on drugs and drug delivery vesicles. VARGHA-BUTLER, E. 1., SVEINSSON, S. J., and POLICOVA, Z., Colloids Surf., 1991, 58, (3), 271–286.
  • Methodology for the preparation of ultra-dispersed polymer systems. VAUTHIER-HOLTZSCHERER, C., BENABBOU, S., SPENLEHAUER, G., VEILLARD, M., and COUVREUR, P., STP Pharma Sci., 1991, 1, (2), 109–116.
  • High liver-to-kidney platinum concentration ratios after targeting of CDDP to the liver with polymer-based microspheres. VERRIJK, R., SMOLDERS, I. J. H., NOTEBORN, H. P. J. M., and BEGG, A. C., Cancer drug Des., 1991, 6, (4), 269.
  • Development, characterization and evaluation of an auto-regulatory delivery system for insulin. VYAS, S. P., KARAJGI, J. S., GOGOI, P. J., and JAIN, N. K., J. Microencapsulation, 1991,8, (2), 235–242.
  • Liposome mediated transfer of human TNF CDNA. WALTHER, W., and RESZKA, R., Eur. J. Cancer, 1991, 27, (Suppl. 3), S89.
  • Influence of formulation methods on the in vitro controlled release of protein from poly(ester) microspheres. WANG, H. T., SCHMITT, E., FI.ANAGAN, D. R., and LINLIARDT, R. J., J. Controlled Release, 1991, 17, (1), 23–31.
  • In vitro binding of free and liposomal-amphotericin B (L-AMPB) to lipoproteins. WASAN, K. M., BRAZEALT, G. A., and LOPEZ-BERESTEIN, G., Pharm. Res., 1991, 8, (10, Suppl.), S214.
  • In vivo responses to different formulations of alginate-polylysine microcapsules in BB-E rats. WATERFALL., M., MCINTYRE, M., and BAIRD, J. D., Diametologia, 1991, 34, (Suppl. 2), A170.
  • Radiolabeling of polymer microspheres for scintigraphic investigations by neutron activation. 1. Incorporation of samarium oxide and its effects on the properties of Eudragit RS: sulfasalazine microspheres. WATTS, P. J., ATKIN, B. P., WILSON, C. G., DAVIES, M. C., and MELIA, C. D., Int. J. Pharm., 1991, 76, (1-2), 55–59.
  • Fourier transform-Raman spectroscopy for the qualitative and quantitative characterization of sulfasalazine-containing polymeric microspheres. WATTS, P. J., TUDOR, A., CHURCH, S. J., HENDRA, P. J., TURNER, P., MELIA, C. D., and DANREs, M. C., Pharm. Res., 1991, 8, (10), 1323–1328.
  • Chemistry and biology of immunotargeted liposomes. WEINER, A. L., Targeted Diagn. Ther., 1990, 3, 305–336.
  • Evaluation of stabilizers for synthetic vesicles and milk fat globules under drying stress. WHITBURN, K. D., and DUNNE, C. P., ACS Symp. Ser., 1991, 448 (Pestic. Residues Food Saf.), 161–181.
  • Induction of cytolytic T cell responses by the repeatless Plasmodium falciparum circum-sporozoite protein molecule incorporated into liposomes. WHITE, K., GORDON, D., GROSS, M., RICHARDS, R. L., AINING, C. R., BALLou, W. R., and KRZYCH, U., Am. J. Trop. Med. Hyg., 1991, 45, (3. Suppl.), 284.
  • Direct intraarterial wall injection of microparticles via a catheter: a potential drug delivery strategy following angioplasty. WILENSKY, R. L., MARCH, K. L., and HATHAWAY, D. R., Am. Heart J., 1991, 122, (4, Pt 1), 1136–1140.
  • Development of radiolabeled albumin microspheres: a comparison of gamma-emitting radioisotopes of iodine (131I) and indium (111In/113In). WII.I.MOTT, N., MURRAY, T., CARLTON, R., CHEN, Y., LOGAN, H., MCCURRACH, G., BESSENT, R. G., GOLDBERG, J. A., ANDERSON, J. et at., Nucl. Med. Biol., 1991, 18, (7), 687–694.
  • Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells. WINN, S. R., TRESCO, P. A., ZIEI.INSKI, B., GREENE, L. A., JAEGER, C. B., and AEBISCHER, P., Exp. Neurol., 1991, 113, (3), 322–329.
  • Relation of mean pixel intensity to concentration of sonicated albumin microspheres effects of ultrasound system settings. WRAY, R. A., QUINONES, M. A., ZOGHBI, W. A., and CHEIRIF, J., Clin. Cardiol., 1991, 14, (11, Suppl. 5), V-23-V–28.
  • In vitro measurement of antigen-specific cell-mediated immune responses using recom-binant HIV-1 proteins adsorbed to latex microspheres. Wu, J. Y., RIGGIN, C. H., SEAI,S, J. R., MURPHY, C. I., and NEWMAN, M. J., J. Immunol. Methods, 1991, 143, (1), 1–9.
  • Antibody-mediated targeting of doxorubicin-containing immunoliposomes to human gastric cancer. XU LIANG, ZHANG XUEYONG, MO JIAN, FAN DAIMING, CHEN XITAO, SUN SHUFEN, Guo ZHENGREH, and WANG DUONING, J. Med. Coll. PLA, 1991, 6, (1), 48–52.
  • Liposome-mediated transformation of Streptomyces chromosomal and plasmid DNA. XU
  • XIAOXUE, ZHANG TINGZHI, and ZHENG YOUXIA. Shettg24./U Gongcheng Xuebao, 1991, 7, (2), 184–187. Anticancer gelatin microspheres with multiple functions. YAN, C., LI, X., CHEN, X., WANG, D., ZHONG, D., TAN, T., and KITANO, H., Biomaterials, 1991, 12, (7), 640–644.
  • Preparation of albendazole liposomes and its effect on Fasciola hepatica in goats. YANG, Y. S., and FUNG, K. F., Acta Vet. Scand. Suppl., 1991, (87), 406–407.
  • Nonsedimentable microvesicles from senescing bean cotyledons contain gel phase-forming phospholipid degradation products. YAO, K., PALIYATH, G., and THOMPSON, J. E., Plant Physiol., 1991, 97, (2), 502–508.
  • Immunologic aspects of liposomes for medical applications. YASUDA, T., J. Jpn. Oil Chem. Soc., 1991, 40, (7), 541–548.
  • Immunogenicity of a haptenated liposome antigen. Influence of microscopic environment around the antigenic determinant, and antigenicity of the liposomal gangliosides. YASUDA, T., and WATARAI, S., Okayama Igakkai Zasshi, 1991, 103, (3), 419–425.
  • Interaction of sodium-potassium ATPase proteoliposomes with palytoxin at picomolar concentrations. YODA, A., ROSNER, M. R., MORRISON, P., and YODA, S., Soc. Gen. Physiol. Ser., 1991, 46, (Pt 2, Sodium Pump: Recent Den.), 499–504.
  • Surface modification of haemoglobin-containing liposomes with polyethylene glycol prevents liposome aggregation in blood plasma. YOSHIOKA, H., Biomaterials, 1991, 12, (9), 861–864.
  • Antitumor effects of alkylphosphocholines in different murine tumor models: use of liposomal preparations. ZEISIG, R., FICHTNER, 1., ARNDT, D., and JUNGMANN, S., Anti-Cancer Drugs, 1991, 2, (4), 411–417.
  • Alginate-coating of islets: a new technique for microencapsulation. ZEKORN, T., SIEBERS, U., HORCHER, A., ZIMMERMANN, U., BRETZEL, R. G., and FEDERLIN, K., Diabetologia, 1991, 34, (Suppl. 2), A169.
  • Polymerization of liposomes. (I). Synthesis of unsaturated liposome monomer. ZHANG LIGUN, ZHOU HONGBING, ZHOU QINGZHONG, ZHOU QIFENG and SUN YANHUI, Gaodeng Xuexiao Huaxue Xuebao, 1990, 11, (9), 1034–1036.
  • Tentative exploration of possibility of the treatment of human chondrosarcoma by im-munoliposome. ZHANG, Y. et al., J. China Med. Univ., 1990, 19, (Suppl.), 19–21.
  • Liposome encapsulated hemoglobin: an oxygen delivery system-red blood cell substitute. ZHENG, S., ZHENG, Y., BEISSINGER, R., SHERWOOD, R., FRESCO, R., GODWIN, J., FAREED, J., and MARTIN, F., Ann. Biomed. Eng., 1991, 19, (5), 608.
  • Studies on the transport pathway of PBCA nanoparticles in ocular tissues. ZIMMER, A., KREUTER, J., and ROBINSON, J. R., J. Microencapsulation, 1991, 8, (4), 497–504.
  • Temperature sensitive liposome encapsulated adriamycin combined with hepatic artery embolization. Zou, Y. Y., Gu, X. Q., and HORIKOSHI, I. M., Acta Pharm. Sin., 1991, 26, (8), 622–626.
  • Temperature-sensitive liposome containing encapsulated adriamycin. Zou, Y. Y., Gu, X. Q., and HORIKOSHI, I. M., Yaoxue Xuebao, 1991, 26, (8), 622–626.
  • ATP-synthesis by reconstituted liposomes containing ATP-synthase from Micrococcus luteus and monomeric bacteriorhodopsin or caged acid. ZWICKER, K., DOSE, K., and NAWROTH, T., Biol. Chem. Hoppe-Seyler, 1991, 372, (9), 783–784.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.